JP2006516145A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006516145A5 JP2006516145A5 JP2004570963A JP2004570963A JP2006516145A5 JP 2006516145 A5 JP2006516145 A5 JP 2006516145A5 JP 2004570963 A JP2004570963 A JP 2004570963A JP 2004570963 A JP2004570963 A JP 2004570963A JP 2006516145 A5 JP2006516145 A5 JP 2006516145A5
- Authority
- JP
- Japan
- Prior art keywords
- amino
- pyrrolidin
- trifluoromethyl
- benzamide
- oxoethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 nitro, amino Chemical group 0.000 claims 667
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 57
- 125000003545 alkoxy group Chemical group 0.000 claims 28
- 125000000217 alkyl group Chemical group 0.000 claims 27
- 125000004385 trihaloalkyl group Chemical group 0.000 claims 26
- 125000003118 aryl group Chemical group 0.000 claims 24
- 229910052736 halogen Inorganic materials 0.000 claims 20
- 150000002367 halogens Chemical class 0.000 claims 20
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 19
- 125000004952 trihaloalkoxy group Chemical group 0.000 claims 19
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims 18
- 125000001072 heteroaryl group Chemical group 0.000 claims 18
- 125000000623 heterocyclic group Chemical group 0.000 claims 18
- 125000004093 cyano group Chemical group *C#N 0.000 claims 17
- 125000003178 carboxy group Chemical class [H]OC(*)=O 0.000 claims 16
- 125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 15
- 125000004001 thioalkyl group Chemical group 0.000 claims 15
- 125000003342 alkenyl group Chemical group 0.000 claims 14
- 125000000304 alkynyl group Chemical group 0.000 claims 14
- PAMCRRDMORMCSM-UHFFFAOYSA-N n-(trifluoromethyl)benzamide Chemical compound FC(F)(F)NC(=O)C1=CC=CC=C1 PAMCRRDMORMCSM-UHFFFAOYSA-N 0.000 claims 14
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 14
- 150000003857 carboxamides Chemical class 0.000 claims 13
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 11
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims 10
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 10
- 125000004103 aminoalkyl group Chemical class 0.000 claims 10
- 125000003710 aryl alkyl group Chemical group 0.000 claims 10
- 150000001875 compounds Chemical class 0.000 claims 10
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims 9
- 229940124530 sulfonamide Drugs 0.000 claims 9
- 150000003456 sulfonamides Chemical class 0.000 claims 9
- 229910052739 hydrogen Inorganic materials 0.000 claims 8
- 229910052757 nitrogen Inorganic materials 0.000 claims 8
- 229910052760 oxygen Inorganic materials 0.000 claims 8
- 229910052717 sulfur Inorganic materials 0.000 claims 8
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 7
- 239000004202 carbamide Substances 0.000 claims 7
- 239000001257 hydrogen Substances 0.000 claims 7
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 7
- 125000004549 quinolin-4-yl group Chemical group N1=CC=C(C2=CC=CC=C12)* 0.000 claims 7
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 6
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims 6
- 125000005160 aryl oxy alkyl group Chemical group 0.000 claims 6
- 125000004104 aryloxy group Chemical group 0.000 claims 6
- 125000002619 bicyclic group Chemical group 0.000 claims 6
- 125000002837 carbocyclic group Chemical group 0.000 claims 6
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 6
- 125000005114 heteroarylalkoxy group Chemical group 0.000 claims 6
- 125000005326 heteroaryloxy alkyl group Chemical group 0.000 claims 6
- 125000005553 heteroaryloxy group Chemical group 0.000 claims 6
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 6
- CYEBJEDOHLIWNP-UHFFFAOYSA-N methanethioamide Chemical compound NC=S CYEBJEDOHLIWNP-UHFFFAOYSA-N 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 6
- 125000001424 substituent group Chemical group 0.000 claims 6
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 6
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 5
- 125000006350 alkyl thio alkyl group Chemical group 0.000 claims 5
- 125000005129 aryl carbonyl group Chemical group 0.000 claims 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 5
- 150000004657 carbamic acid derivatives Chemical class 0.000 claims 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 5
- 125000005223 heteroarylcarbonyl group Chemical group 0.000 claims 5
- 125000005143 heteroarylsulfonyl group Chemical group 0.000 claims 5
- 239000001301 oxygen Substances 0.000 claims 5
- 239000011593 sulfur Substances 0.000 claims 5
- 125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 claims 4
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims 4
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 claims 4
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 claims 4
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 4
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims 4
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 4
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 claims 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 4
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 4
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 claims 4
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical group FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 claims 4
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical compound C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims 3
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 claims 3
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 claims 3
- 125000006306 4-iodophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1I 0.000 claims 3
- 239000005977 Ethylene Substances 0.000 claims 3
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 3
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims 3
- 125000005018 aryl alkenyl group Chemical group 0.000 claims 3
- 125000005127 aryl alkoxy alkyl group Chemical group 0.000 claims 3
- 125000005015 aryl alkynyl group Chemical group 0.000 claims 3
- 125000005100 aryl amino carbonyl group Chemical group 0.000 claims 3
- 125000001769 aryl amino group Chemical group 0.000 claims 3
- 125000004658 aryl carbonyl amino group Chemical group 0.000 claims 3
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims 3
- 125000005164 aryl thioalkyl group Chemical group 0.000 claims 3
- KXDAEFPNCMNJSK-UHFFFAOYSA-N benzene carboxamide Natural products NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims 3
- 125000003917 carbamoyl group Chemical class [H]N([H])C(*)=O 0.000 claims 3
- 125000004982 dihaloalkyl group Chemical group 0.000 claims 3
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 claims 3
- 125000001188 haloalkyl group Chemical group 0.000 claims 3
- 125000004447 heteroarylalkenyl group Chemical group 0.000 claims 3
- 125000005312 heteroarylalkynyl group Chemical group 0.000 claims 3
- 125000005241 heteroarylamino group Chemical group 0.000 claims 3
- 125000005222 heteroarylaminocarbonyl group Chemical group 0.000 claims 3
- 125000005224 heteroarylcarbonylamino group Chemical group 0.000 claims 3
- 125000005842 heteroatom Chemical group 0.000 claims 3
- 125000002962 imidazol-1-yl group Chemical group [*]N1C([H])=NC([H])=C1[H] 0.000 claims 3
- 150000003949 imides Chemical class 0.000 claims 3
- 125000004501 isothiazol-5-yl group Chemical group S1N=CC=C1* 0.000 claims 3
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 claims 3
- 239000002207 metabolite Substances 0.000 claims 3
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims 3
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims 3
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 claims 3
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 3
- 239000000651 prodrug Substances 0.000 claims 3
- 229940002612 prodrug Drugs 0.000 claims 3
- 125000004307 pyrazin-2-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 claims 3
- 125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 239000012453 solvate Substances 0.000 claims 3
- 125000003003 spiro group Chemical group 0.000 claims 3
- 241000124008 Mammalia Species 0.000 claims 2
- HMFHBZSHGGEWLO-KKQCNMDGSA-N beta-D-xylofuranose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@H]1O HMFHBZSHGGEWLO-KKQCNMDGSA-N 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 125000002140 imidazol-4-yl group Chemical group [H]N1C([H])=NC([*])=C1[H] 0.000 claims 2
- 150000002576 ketones Chemical class 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 2
- VVCJMAZMIRREGR-MVBMGLOESA-N n-[2-[[(3r)-1-(4-hydroxy-4-pyrazin-2-ylcyclohexyl)pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1N=CC=NC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 VVCJMAZMIRREGR-MVBMGLOESA-N 0.000 claims 2
- MWYZERNYUXQMHI-IOXNAGQWSA-N n-[2-[[(3s,4s)-1-[4-(4-cyanophenyl)-4-hydroxycyclohexyl]-4-ethoxypyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1OCC)C1CCC(O)(CC1)C=1C=CC(=CC=1)C#N)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 MWYZERNYUXQMHI-IOXNAGQWSA-N 0.000 claims 2
- DCFDUNBMHKVEMK-PGPPMQCXSA-N n-[2-[[(3s,4s)-4-hydroxy-1-(4-hydroxy-4-pyridin-2-ylcyclohexyl)pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1O)C1CCC(O)(CC1)C=1N=CC=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 DCFDUNBMHKVEMK-PGPPMQCXSA-N 0.000 claims 2
- 150000002923 oximes Chemical class 0.000 claims 2
- 125000002206 pyridazin-3-yl group Chemical group [H]C1=C([H])C([H])=C(*)N=N1 0.000 claims 2
- 125000004940 pyridazin-4-yl group Chemical group N1=NC=C(C=C1)* 0.000 claims 2
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical compound C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 claims 1
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 1
- 125000004793 2,2,2-trifluoroethoxy group Chemical group FC(CO*)(F)F 0.000 claims 1
- FRHIQRUGEWKYKJ-MDPMHESRSA-N 2-(1,3-benzothiazol-2-ylamino)-n-[(3r)-1-(4-hydroxy-4-pyridin-2-ylcyclohexyl)pyrrolidin-3-yl]acetamide Chemical compound C1CC(N2C[C@@H](CC2)NC(=O)CNC=2SC3=CC=CC=C3N=2)CCC1(O)C1=CC=CC=N1 FRHIQRUGEWKYKJ-MDPMHESRSA-N 0.000 claims 1
- JNQUECFEWPYNIM-LNCJBJJNSA-N 2-[1-hydroxy-4-[(3r)-3-[[2-[[3-(trifluoromethyl)benzoyl]amino]acetyl]amino]pyrrolidin-1-yl]cyclohexyl]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)N)=CN=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 JNQUECFEWPYNIM-LNCJBJJNSA-N 0.000 claims 1
- MYSFYUNLGKULPA-VLNJMECTSA-N 2-[1-hydroxy-4-[(3r)-3-[[2-[[3-(trifluoromethyl)benzoyl]amino]acetyl]amino]pyrrolidin-1-yl]cyclohexyl]-n,n-dimethyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)N(C)C)=CN=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 MYSFYUNLGKULPA-VLNJMECTSA-N 0.000 claims 1
- WDIQRIWLNMOHQT-MDPMHESRSA-N 2-[1-hydroxy-4-[(3r)-3-[[2-[[3-(trifluoromethyl)benzoyl]amino]acetyl]amino]pyrrolidin-1-yl]cyclohexyl]-n-methyl-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NC)=CN=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 WDIQRIWLNMOHQT-MDPMHESRSA-N 0.000 claims 1
- INXIZQQEZMHDRQ-NHKQPKSZSA-N 2-fluoro-4-[1-hydroxy-4-[(3r)-3-[[2-[[3-(trifluoromethyl)benzoyl]amino]acetyl]amino]pyrrolidin-1-yl]cyclohexyl]-n-methylbenzamide Chemical compound C1=C(F)C(C(=O)NC)=CC=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 INXIZQQEZMHDRQ-NHKQPKSZSA-N 0.000 claims 1
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 claims 1
- FICAQKBMCKEFDI-UHFFFAOYSA-N 3,5-dimethyl-1,2-oxazole Chemical compound CC=1C=C(C)ON=1 FICAQKBMCKEFDI-UHFFFAOYSA-N 0.000 claims 1
- XZEBWWBBFUIKED-HFSRXPFLSA-N 3-[1-hydroxy-4-[(3r)-3-[[2-[[3-(trifluoromethyl)benzoyl]amino]acetyl]amino]pyrrolidin-1-yl]cyclohexyl]-4-methoxy-n,n-dimethylbenzamide Chemical compound COC1=CC=C(C(=O)N(C)C)C=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 XZEBWWBBFUIKED-HFSRXPFLSA-N 0.000 claims 1
- PPULXIYWPSNVNY-MSUMSUTISA-N 3-[1-hydroxy-4-[(3r)-3-[[2-[[3-(trifluoromethyl)benzoyl]amino]acetyl]amino]pyrrolidin-1-yl]cyclohexyl]-4-methoxy-n-methylbenzamide Chemical compound CNC(=O)C1=CC=C(OC)C(C2(O)CCC(CC2)N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)=C1 PPULXIYWPSNVNY-MSUMSUTISA-N 0.000 claims 1
- MFKRLNKKPKMKFT-QXIWCURZSA-N 3-[1-hydroxy-4-[(3r)-3-[[2-[[3-(trifluoromethyl)benzoyl]amino]acetyl]amino]pyrrolidin-1-yl]cyclohexyl]-n,n-dimethylbenzamide Chemical compound CN(C)C(=O)C1=CC=CC(C2(O)CCC(CC2)N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)=C1 MFKRLNKKPKMKFT-QXIWCURZSA-N 0.000 claims 1
- NRMZSYGTSQRQOJ-WXFIPNSDSA-N 3-[1-hydroxy-4-[(3r)-3-[[2-[[3-(trifluoromethyl)benzoyl]amino]acetyl]amino]pyrrolidin-1-yl]cyclohexyl]-n-methylbenzamide Chemical compound CNC(=O)C1=CC=CC(C2(O)CCC(CC2)N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)=C1 NRMZSYGTSQRQOJ-WXFIPNSDSA-N 0.000 claims 1
- QIGXOWCTACMDGB-JPKAMZIXSA-N 4-[1-hydroxy-4-[(3r)-3-[[2-[[3-(trifluoromethyl)benzoyl]amino]acetyl]amino]pyrrolidin-1-yl]cyclohexyl]-n,n,2-trimethylbenzamide Chemical compound C1=C(C)C(C(=O)N(C)C)=CC=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 QIGXOWCTACMDGB-JPKAMZIXSA-N 0.000 claims 1
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- 102100031151 C-C chemokine receptor type 2 Human genes 0.000 claims 1
- 101710149815 C-C chemokine receptor type 2 Proteins 0.000 claims 1
- 102100035875 C-C chemokine receptor type 5 Human genes 0.000 claims 1
- 101710149870 C-C chemokine receptor type 5 Proteins 0.000 claims 1
- 102000009410 Chemokine receptor Human genes 0.000 claims 1
- 108050000299 Chemokine receptor Proteins 0.000 claims 1
- 206010061598 Immunodeficiency Diseases 0.000 claims 1
- 208000029462 Immunodeficiency disease Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 206010052779 Transplant rejections Diseases 0.000 claims 1
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- WJJMNDUMQPNECX-UHFFFAOYSA-N dipicolinic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=N1 WJJMNDUMQPNECX-UHFFFAOYSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 125000001145 hydrido group Chemical group *[H] 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 230000007813 immunodeficiency Effects 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 206010025135 lupus erythematosus Diseases 0.000 claims 1
- 125000006626 methoxycarbonylamino group Chemical group 0.000 claims 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims 1
- DODIQVYFIPAFNG-BGPPBHKUSA-N n-[(3r)-1-[4-hydroxy-4-(2-propan-2-yl-1,3-thiazol-5-yl)cyclohexyl]pyrrolidin-3-yl]-4-oxo-4-[3-(trifluoromethyl)phenyl]butanamide Chemical compound S1C(C(C)C)=NC=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)CCC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 DODIQVYFIPAFNG-BGPPBHKUSA-N 0.000 claims 1
- YJNIOQCPYIOBNA-CMZFYYCHSA-N n-[(3r)-1-[4-hydroxy-4-[2-(methoxymethyl)-1,3-thiazol-5-yl]cyclohexyl]pyrrolidin-3-yl]-3-[3-(trifluoromethyl)phenyl]-4,5-dihydro-1,2-oxazole-5-carboxamide Chemical compound S1C(COC)=NC=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)C2ON=C(C2)C=2C=C(C=CC=2)C(F)(F)F)CC1 YJNIOQCPYIOBNA-CMZFYYCHSA-N 0.000 claims 1
- SLBGEOHOQYOJDQ-GBFLJEJBSA-N n-[(3r)-1-[4-hydroxy-4-[5-(methoxymethyl)-1,3-thiazol-2-yl]cyclohexyl]pyrrolidin-3-yl]-2-[[3-(trifluoromethyl)phenyl]sulfonylamino]acetamide Chemical compound S1C(COC)=CN=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)CNS(=O)(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 SLBGEOHOQYOJDQ-GBFLJEJBSA-N 0.000 claims 1
- QYGUIBXTDARAMJ-USEFPYCQSA-N n-[(3r)-1-[4-hydroxy-4-[5-(methoxymethyl)-1,3-thiazol-2-yl]cyclohexyl]pyrrolidin-3-yl]-4-oxo-4-[3-(trifluoromethyl)phenyl]butanamide Chemical compound S1C(COC)=CN=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)CCC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 QYGUIBXTDARAMJ-USEFPYCQSA-N 0.000 claims 1
- OVWDKALMNVPMII-DUHUICASSA-N n-[2-[[(3r)-1-(2-hydroxy-2-pyridin-3-yl-5-bicyclo[2.2.2]octanyl)pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CC2CCC1CC2(O)C=1C=NC=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 OVWDKALMNVPMII-DUHUICASSA-N 0.000 claims 1
- JRQYGNBKTFKPQJ-HHHXNRCGSA-N n-[2-[[(3r)-1-(4,4-diphenylcyclohexyl)pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound FC(F)(F)C1=CC=CC(C(=O)NCC(=O)N[C@H]2CN(CC2)C2CCC(CC2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 JRQYGNBKTFKPQJ-HHHXNRCGSA-N 0.000 claims 1
- PWYLFYWUKYSYEE-UZGSZPBKSA-N n-[2-[[(3r)-1-(4-fluoro-4-pyridin-3-ylcyclohexyl)pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound FC(F)(F)C1=CC=CC(C(=O)NCC(=O)N[C@H]2CN(CC2)C2CCC(F)(CC2)C=2C=NC=CC=2)=C1 PWYLFYWUKYSYEE-UZGSZPBKSA-N 0.000 claims 1
- LDYSIQBWKUBFFP-PQXIJOGNSA-N n-[2-[[(3r)-1-(4-hydroxy-4-phenylcyclohexyl)pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=CC=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 LDYSIQBWKUBFFP-PQXIJOGNSA-N 0.000 claims 1
- HBTZTMSFUWNTTQ-RZFJCUDFSA-N n-[2-[[(3r)-1-(4-hydroxy-4-pyridazin-4-ylcyclohexyl)pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=NN=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 HBTZTMSFUWNTTQ-RZFJCUDFSA-N 0.000 claims 1
- DEVTYEWCSUXPPX-KDARRYODSA-N n-[2-[[(3r)-1-(4-hydroxy-4-pyridin-2-ylcyclohexyl)pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1N=CC=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 DEVTYEWCSUXPPX-KDARRYODSA-N 0.000 claims 1
- KUWNDUYYSZHFCP-UZGSZPBKSA-N n-[2-[[(3r)-1-(4-hydroxy-4-pyridin-3-ylcyclohexyl)pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=NC=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 KUWNDUYYSZHFCP-UZGSZPBKSA-N 0.000 claims 1
- HCWVPYIWVWLGPP-UZGSZPBKSA-N n-[2-[[(3r)-1-(4-hydroxy-4-pyridin-4-ylcyclohexyl)pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=CN=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 HCWVPYIWVWLGPP-UZGSZPBKSA-N 0.000 claims 1
- SAOZWMYDEMCMDX-MVBMGLOESA-N n-[2-[[(3r)-1-(4-hydroxy-4-pyrimidin-2-ylcyclohexyl)pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1N=CC=CN=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 SAOZWMYDEMCMDX-MVBMGLOESA-N 0.000 claims 1
- YAFRFZRHFCETGN-MVBMGLOESA-N n-[2-[[(3r)-1-(4-hydroxy-4-pyrimidin-4-ylcyclohexyl)pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1N=CN=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 YAFRFZRHFCETGN-MVBMGLOESA-N 0.000 claims 1
- GAKKMSMTYSFQMD-RZFJCUDFSA-N n-[2-[[(3r)-1-(4-hydroxy-4-pyrimidin-5-ylcyclohexyl)pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=NC=NC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 GAKKMSMTYSFQMD-RZFJCUDFSA-N 0.000 claims 1
- XGBQQIOZTRKZBT-TZRRMPRUSA-N n-[2-[[(3r)-1-[(1r,2s)-2-(benzylamino)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound FC(F)(F)C1=CC=CC(C(=O)NCC(=O)N[C@H]2CN(CC2)[C@H]2[C@H](CCCC2)NCC=2C=CC=CC=2)=C1 XGBQQIOZTRKZBT-TZRRMPRUSA-N 0.000 claims 1
- ZSIFWDIDYHWREH-XPWALMASSA-N n-[2-[[(3r)-1-[(1r,2s)-2-benzamidocyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound FC(F)(F)C1=CC=CC(C(=O)NCC(=O)N[C@H]2CN(CC2)[C@H]2[C@H](CCCC2)NC(=O)C=2C=CC=CC=2)=C1 ZSIFWDIDYHWREH-XPWALMASSA-N 0.000 claims 1
- QCBZGANAMALUIF-GEUIHZRBSA-N n-[2-[[(3r)-1-[4-(1,3-benzothiazol-2-yl)-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1SC2=CC=CC=C2N=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 QCBZGANAMALUIF-GEUIHZRBSA-N 0.000 claims 1
- VFXMSYMTCIHZMS-AGHUKTAOSA-N n-[2-[[(3r)-1-[4-(2-cyclopropylpyrimidin-5-yl)-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=NC(=NC=1)C1CC1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 VFXMSYMTCIHZMS-AGHUKTAOSA-N 0.000 claims 1
- RRZBQGMHUDBETI-JNDNBTNTSA-N n-[2-[[(3r)-1-[4-(2-ethoxy-1,3-thiazol-5-yl)-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound S1C(OCC)=NC=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 RRZBQGMHUDBETI-JNDNBTNTSA-N 0.000 claims 1
- JOOIRINNXLRETK-JNDNBTNTSA-N n-[2-[[(3r)-1-[4-(2-ethyl-1,3-thiazol-5-yl)-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound S1C(CC)=NC=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 JOOIRINNXLRETK-JNDNBTNTSA-N 0.000 claims 1
- XKGXFERZTCXCRX-USEFPYCQSA-N n-[2-[[(3r)-1-[4-(2-fluorophenyl)-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C(=CC=CC=1)F)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 XKGXFERZTCXCRX-USEFPYCQSA-N 0.000 claims 1
- GKZCUSRINAJTLZ-PQXIJOGNSA-N n-[2-[[(3r)-1-[4-(3-chlorophenyl)-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=C(Cl)C=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 GKZCUSRINAJTLZ-PQXIJOGNSA-N 0.000 claims 1
- SBOSOBRMGSJSDR-SVRAFRINSA-N n-[2-[[(3r)-1-[4-(3-cyanophenyl)-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=C(C=CC=1)C#N)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 SBOSOBRMGSJSDR-SVRAFRINSA-N 0.000 claims 1
- HPSIJFYOFLSSGV-PQXIJOGNSA-N n-[2-[[(3r)-1-[4-(3-fluorophenyl)-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=C(F)C=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 HPSIJFYOFLSSGV-PQXIJOGNSA-N 0.000 claims 1
- UNZDFKYTSNRJMU-PQXIJOGNSA-N n-[2-[[(3r)-1-[4-(4-bromophenyl)-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=CC(Br)=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 UNZDFKYTSNRJMU-PQXIJOGNSA-N 0.000 claims 1
- BBEWJCVHPULRSV-PQXIJOGNSA-N n-[2-[[(3r)-1-[4-(4-chlorophenyl)-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=CC(Cl)=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 BBEWJCVHPULRSV-PQXIJOGNSA-N 0.000 claims 1
- CFIMBXSJBVDUEK-SVRAFRINSA-N n-[2-[[(3r)-1-[4-(4-cyanophenyl)-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=CC(=CC=1)C#N)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 CFIMBXSJBVDUEK-SVRAFRINSA-N 0.000 claims 1
- PHCBNASWBBFZMV-PQXIJOGNSA-N n-[2-[[(3r)-1-[4-(4-fluorophenyl)-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=CC(F)=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 PHCBNASWBBFZMV-PQXIJOGNSA-N 0.000 claims 1
- ZEGPYANSCZFTDP-KDARRYODSA-N n-[2-[[(3r)-1-[4-(5-bromopyridin-2-yl)-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1N=CC(Br)=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 ZEGPYANSCZFTDP-KDARRYODSA-N 0.000 claims 1
- AXDCXMOZTWUHQV-JMOWIOHXSA-N n-[2-[[(3r)-1-[4-(5-cyanopyridin-2-yl)-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1N=CC(=CC=1)C#N)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 AXDCXMOZTWUHQV-JMOWIOHXSA-N 0.000 claims 1
- FCSHUTWMCDMEGA-JNDNBTNTSA-N n-[2-[[(3r)-1-[4-(5-ethyl-1,3-thiazol-2-yl)-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound S1C(CC)=CN=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 FCSHUTWMCDMEGA-JNDNBTNTSA-N 0.000 claims 1
- GYNZOMSRISFPJH-KDARRYODSA-N n-[2-[[(3r)-1-[4-(6-bromopyridin-3-yl)-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=NC(Br)=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 GYNZOMSRISFPJH-KDARRYODSA-N 0.000 claims 1
- YWCYAZZTMVIAHR-PQXIJOGNSA-N n-[2-[[(3r)-1-[4-(6-cyanopyridin-3-yl)-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=NC(=CC=1)C#N)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 YWCYAZZTMVIAHR-PQXIJOGNSA-N 0.000 claims 1
- GBHFJHHZNPQVSF-AGHUKTAOSA-N n-[2-[[(3r)-1-[4-(6-ethoxypyridin-3-yl)-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound C1=NC(OCC)=CC=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 GBHFJHHZNPQVSF-AGHUKTAOSA-N 0.000 claims 1
- MSZTUQIDVIKVMT-PDRFFQIWSA-N n-[2-[[(3r)-1-[4-(6-methoxypyridin-3-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound C1=NC(OC)=CC=C1C1CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 MSZTUQIDVIKVMT-PDRFFQIWSA-N 0.000 claims 1
- JPEWHBVTMYJRTL-FMGHMSBISA-N n-[2-[[(3r)-1-[4-(6-morpholin-4-ylpyridin-3-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound FC(F)(F)C1=CC=CC(C(=O)NCC(=O)N[C@H]2CN(CC2)C2CCC(CC2)C=2C=NC(=CC=2)N2CCOCC2)=C1 JPEWHBVTMYJRTL-FMGHMSBISA-N 0.000 claims 1
- FFVOCIHNNQEMHX-JMOWIOHXSA-N n-[2-[[(3r)-1-[4-[2-(2-fluoroethoxy)pyrimidin-5-yl]-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=NC(OCCF)=NC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 FFVOCIHNNQEMHX-JMOWIOHXSA-N 0.000 claims 1
- YPZGWTDNAHGJSU-WXFIPNSDSA-N n-[2-[[(3r)-1-[4-[3-fluoro-4-(methoxymethyl)phenyl]-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound C1=C(F)C(COC)=CC=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 YPZGWTDNAHGJSU-WXFIPNSDSA-N 0.000 claims 1
- NRMQYACWGBKIJP-OQERGNBTSA-N n-[2-[[(3r)-1-[4-[4-(4,6-dimethylpyrimidin-5-yl)phenyl]-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound CC1=NC=NC(C)=C1C1=CC=C(C2(O)CCC(CC2)N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)C=C1 NRMQYACWGBKIJP-OQERGNBTSA-N 0.000 claims 1
- NMNSNBYHMUBGTJ-FMGHMSBISA-N n-[2-[[(3r)-1-[4-[4-(dimethylcarbamoyl)phenyl]cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound C1=CC(C(=O)N(C)C)=CC=C1C1CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 NMNSNBYHMUBGTJ-FMGHMSBISA-N 0.000 claims 1
- ZUTKGMWAIOUQAM-QXIWCURZSA-N n-[2-[[(3r)-1-[4-[4-[(dimethylamino)methyl]-3-fluorophenyl]-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound C1=C(F)C(CN(C)C)=CC=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 ZUTKGMWAIOUQAM-QXIWCURZSA-N 0.000 claims 1
- CTSQWOMAUBANMB-YAAXVGMDSA-N n-[2-[[(3r)-1-[4-[4-[(dimethylamino)methyl]phenyl]-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound C1=CC(CN(C)C)=CC=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 CTSQWOMAUBANMB-YAAXVGMDSA-N 0.000 claims 1
- QBDRJATXOIZIRU-ZRBPSXSDSA-N n-[2-[[(3r)-1-[4-[4-[hydroxy(pyridin-3-yl)methyl]phenyl]cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)C1=CC=C(C=C1)C(O)C=1C=NC=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 QBDRJATXOIZIRU-ZRBPSXSDSA-N 0.000 claims 1
- WKDBHJZKXGSQJQ-WTUPZXKFSA-N n-[2-[[(3r)-1-[4-[5-(1-benzofuran-2-yl)pyridin-2-yl]-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1N=CC(=CC=1)C=1OC2=CC=CC=C2C=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 WKDBHJZKXGSQJQ-WTUPZXKFSA-N 0.000 claims 1
- AGGPCJIRNGVERN-ANTXIRGESA-N n-[2-[[(3r)-1-[4-[5-(2-formylphenyl)pyridin-2-yl]-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1N=CC(=CC=1)C=1C(=CC=CC=1)C=O)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 AGGPCJIRNGVERN-ANTXIRGESA-N 0.000 claims 1
- SARWSDAVOMAFKJ-QFYHAUMRSA-N n-[2-[[(3r)-1-[4-[5-(3,4-difluorophenyl)pyridin-2-yl]-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1N=CC(=CC=1)C=1C=C(F)C(F)=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 SARWSDAVOMAFKJ-QFYHAUMRSA-N 0.000 claims 1
- XFBHCRHKUGNPCX-NGFHQYDQSA-N n-[2-[[(3r)-1-[4-[5-(3-acetylphenyl)pyridin-2-yl]-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound CC(=O)C1=CC=CC(C=2C=NC(=CC=2)C2(O)CCC(CC2)N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)=C1 XFBHCRHKUGNPCX-NGFHQYDQSA-N 0.000 claims 1
- FXSVUSGYIRWVPS-DCWSAZFOSA-N n-[2-[[(3r)-1-[4-[5-(4-fluorophenyl)pyridin-2-yl]-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1N=CC(=CC=1)C=1C=CC(F)=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 FXSVUSGYIRWVPS-DCWSAZFOSA-N 0.000 claims 1
- MHCKPQQAIJUGBK-WXFIPNSDSA-N n-[2-[[(3r)-1-[4-[5-[(dimethylamino)methyl]pyridin-2-yl]-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N1=CC(CN(C)C)=CC=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 MHCKPQQAIJUGBK-WXFIPNSDSA-N 0.000 claims 1
- XQSVMPYHBRJHCB-SDPJGKNGSA-N n-[2-[[(3r)-1-[4-[5-[(dimethylamino)methyl]pyridin-2-yl]cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N1=CC(CN(C)C)=CC=C1C1CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 XQSVMPYHBRJHCB-SDPJGKNGSA-N 0.000 claims 1
- DIYZTCHYQUDYKS-SOSILRMKSA-N n-[2-[[(3r)-1-[4-[5-[2-[(dimethylamino)methyl]phenyl]pyridin-2-yl]-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound CN(C)CC1=CC=CC=C1C1=CC=C(C2(O)CCC(CC2)N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)N=C1 DIYZTCHYQUDYKS-SOSILRMKSA-N 0.000 claims 1
- JQKJTACJDXVKRD-BGPPBHKUSA-N n-[2-[[(3r)-1-[4-[6-(2,2-difluoroethoxy)pyridin-3-yl]-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=NC(OCC(F)F)=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 JQKJTACJDXVKRD-BGPPBHKUSA-N 0.000 claims 1
- MKUKWTGAMYNNAC-AGHUKTAOSA-N n-[2-[[(3r)-1-[4-[6-(2-fluoroethoxy)pyridin-3-yl]-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=NC(OCCF)=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 MKUKWTGAMYNNAC-AGHUKTAOSA-N 0.000 claims 1
- CJBYIXYFDKYORO-WXFIPNSDSA-N n-[2-[[(3r)-1-[4-[6-(azetidin-1-yl)pyridin-3-yl]-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=NC(=CC=1)N1CCC1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 CJBYIXYFDKYORO-WXFIPNSDSA-N 0.000 claims 1
- JZCKGGKZEXPDFX-WXFIPNSDSA-N n-[2-[[(3r)-1-[4-[6-(cyclopropylamino)pyridin-3-yl]-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=NC(NC2CC2)=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 JZCKGGKZEXPDFX-WXFIPNSDSA-N 0.000 claims 1
- UKXLYRLVJUIOEA-AGHUKTAOSA-N n-[2-[[(3r)-1-[4-[6-(dimethylamino)pyridin-3-yl]-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound C1=NC(N(C)C)=CC=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 UKXLYRLVJUIOEA-AGHUKTAOSA-N 0.000 claims 1
- KMUBFOKFLMHXIS-PVMJWQCPSA-N n-[2-[[(3r)-1-[4-[6-[hydroxy(pyridin-3-yl)methyl]pyridin-3-yl]cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound C=1C=C(C2CCC(CC2)N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)C=NC=1C(O)C1=CC=CN=C1 KMUBFOKFLMHXIS-PVMJWQCPSA-N 0.000 claims 1
- ZCIAGEMLCOBLHP-PDDLGQBUSA-N n-[2-[[(3r)-1-[4-fluoro-4-(1,3-thiazol-2-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound FC(F)(F)C1=CC=CC(C(=O)NCC(=O)N[C@H]2CN(CC2)C2CCC(F)(CC2)C=2SC=CN=2)=C1 ZCIAGEMLCOBLHP-PDDLGQBUSA-N 0.000 claims 1
- QEPLAAIBUWSCKZ-JMOWIOHXSA-N n-[2-[[(3r)-1-[4-fluoro-4-(6-methoxypyridin-3-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound C1=NC(OC)=CC=C1C1(F)CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 QEPLAAIBUWSCKZ-JMOWIOHXSA-N 0.000 claims 1
- MVJLLZMAJRFREX-PDDLGQBUSA-N n-[2-[[(3r)-1-[4-hydroxy-4-(1,3-thiazol-2-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1SC=CN=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 MVJLLZMAJRFREX-PDDLGQBUSA-N 0.000 claims 1
- XTMUALZZEORQKQ-AGHUKTAOSA-N n-[2-[[(3r)-1-[4-hydroxy-4-(1h-indazol-5-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=C2C=NNC2=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 XTMUALZZEORQKQ-AGHUKTAOSA-N 0.000 claims 1
- MZEXAFCJVVIRSP-KDARRYODSA-N n-[2-[[(3r)-1-[4-hydroxy-4-(2-methoxypyrimidin-5-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound C1=NC(OC)=NC=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 MZEXAFCJVVIRSP-KDARRYODSA-N 0.000 claims 1
- FJKABBHTEABIJD-MVBMGLOESA-N n-[2-[[(3r)-1-[4-hydroxy-4-(2-methyl-1,3-thiazol-5-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound S1C(C)=NC=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 FJKABBHTEABIJD-MVBMGLOESA-N 0.000 claims 1
- JWICVTLZTGMNFQ-BGPPBHKUSA-N n-[2-[[(3r)-1-[4-hydroxy-4-(2-morpholin-4-yl-1,3-thiazol-4-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1N=C(SC=1)N1CCOCC1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 JWICVTLZTGMNFQ-BGPPBHKUSA-N 0.000 claims 1
- SBWSIJJXKGWBGI-USEFPYCQSA-N n-[2-[[(3r)-1-[4-hydroxy-4-(2-propan-2-yl-1,3-thiazol-5-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound S1C(C(C)C)=NC=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 SBWSIJJXKGWBGI-USEFPYCQSA-N 0.000 claims 1
- IQYTZDPZFOAORZ-NHKQPKSZSA-N n-[2-[[(3r)-1-[4-hydroxy-4-(2-pyridin-2-yl-1,3-thiazol-5-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1SC(=NC=1)C=1N=CC=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 IQYTZDPZFOAORZ-NHKQPKSZSA-N 0.000 claims 1
- KQBZIQGRGZGAMB-VEODAXLASA-N n-[2-[[(3r)-1-[4-hydroxy-4-(2-pyridin-3-yl-1,3-thiazol-5-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1SC(=NC=1)C=1C=NC=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 KQBZIQGRGZGAMB-VEODAXLASA-N 0.000 claims 1
- PQALSDWZWDNBPE-BGPPBHKUSA-N n-[2-[[(3r)-1-[4-hydroxy-4-(2-pyrrolidin-1-yl-1,3-thiazol-5-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1SC(=NC=1)N1CCCC1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 PQALSDWZWDNBPE-BGPPBHKUSA-N 0.000 claims 1
- FYRWJIZNXHBLFT-PQXIJOGNSA-N n-[2-[[(3r)-1-[4-hydroxy-4-(4-iodophenyl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=CC(I)=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 FYRWJIZNXHBLFT-PQXIJOGNSA-N 0.000 claims 1
- SFXGMIKADNKNJK-MVBMGLOESA-N n-[2-[[(3r)-1-[4-hydroxy-4-(4-methyl-1,3-thiazol-2-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound CC1=CSC(C2(O)CCC(CC2)N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)=N1 SFXGMIKADNKNJK-MVBMGLOESA-N 0.000 claims 1
- YKSPNNYIWLFVCY-SVRAFRINSA-N n-[2-[[(3r)-1-[4-hydroxy-4-(4-methylphenyl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound C1=CC(C)=CC=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 YKSPNNYIWLFVCY-SVRAFRINSA-N 0.000 claims 1
- DPVGMNQRQWUMTE-JMOWIOHXSA-N n-[2-[[(3r)-1-[4-hydroxy-4-(4-methylpyridin-2-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound CC1=CC=NC(C2(O)CCC(CC2)N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)=C1 DPVGMNQRQWUMTE-JMOWIOHXSA-N 0.000 claims 1
- AILFACXPIFCOQB-PXLQRDNWSA-N n-[2-[[(3r)-1-[4-hydroxy-4-(4-morpholin-4-ylphenyl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=CC(=CC=1)N1CCOCC1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 AILFACXPIFCOQB-PXLQRDNWSA-N 0.000 claims 1
- HLAVOYXHFGNRJF-FVEFLQRYSA-N n-[2-[[(3r)-1-[4-hydroxy-4-(4-pyridin-3-ylphenyl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=CC(=CC=1)C=1C=NC=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 HLAVOYXHFGNRJF-FVEFLQRYSA-N 0.000 claims 1
- WXXCXHHGOPLTKW-XNORXSBBSA-N n-[2-[[(3r)-1-[4-hydroxy-4-(4-pyrimidin-2-ylphenyl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=CC(=CC=1)C=1N=CC=CN=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 WXXCXHHGOPLTKW-XNORXSBBSA-N 0.000 claims 1
- MAOMEWPFIBYKLH-PLKPZTHQSA-N n-[2-[[(3r)-1-[4-hydroxy-4-(4-pyrimidin-5-ylphenyl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=CC(=CC=1)C=1C=NC=NC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 MAOMEWPFIBYKLH-PLKPZTHQSA-N 0.000 claims 1
- CXHZYVNAZPGLQE-MVBMGLOESA-N n-[2-[[(3r)-1-[4-hydroxy-4-(5-methyl-1,3-thiazol-2-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound S1C(C)=CN=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 CXHZYVNAZPGLQE-MVBMGLOESA-N 0.000 claims 1
- OSVAVCIMNDJGDX-JMOWIOHXSA-N n-[2-[[(3r)-1-[4-hydroxy-4-(5-methylpyridin-2-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N1=CC(C)=CC=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 OSVAVCIMNDJGDX-JMOWIOHXSA-N 0.000 claims 1
- UWIZRACVSVVZDG-ASNZNYLFSA-N n-[2-[[(3r)-1-[4-hydroxy-4-(5-phenyl-1,3-thiazol-2-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1SC(=CN=1)C=1C=CC=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 UWIZRACVSVVZDG-ASNZNYLFSA-N 0.000 claims 1
- WTDGGNXGJDFBJI-USEFPYCQSA-N n-[2-[[(3r)-1-[4-hydroxy-4-(5-propyl-1,3-thiazol-2-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound S1C(CCC)=CN=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 WTDGGNXGJDFBJI-USEFPYCQSA-N 0.000 claims 1
- NTSGLCOWEAWPMA-NHKQPKSZSA-N n-[2-[[(3r)-1-[4-hydroxy-4-(5-pyridin-2-yl-1,3-thiazol-2-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1SC(=CN=1)C=1N=CC=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 NTSGLCOWEAWPMA-NHKQPKSZSA-N 0.000 claims 1
- XNYRGJBLCSJWRJ-VEODAXLASA-N n-[2-[[(3r)-1-[4-hydroxy-4-(5-pyridin-3-yl-1,3-thiazol-2-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1SC(=CN=1)C=1C=NC=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 XNYRGJBLCSJWRJ-VEODAXLASA-N 0.000 claims 1
- RTKCKMGLSJBINS-ASNZNYLFSA-N n-[2-[[(3r)-1-[4-hydroxy-4-(5-pyrimidin-2-ylpyridin-2-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1N=CC(=CC=1)C=1N=CC=CN=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 RTKCKMGLSJBINS-ASNZNYLFSA-N 0.000 claims 1
- GPFQGPRBUCHYKV-QXIWCURZSA-N n-[2-[[(3r)-1-[4-hydroxy-4-(5-pyrimidin-5-ylpyridin-2-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1N=CC(=CC=1)C=1C=NC=NC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 GPFQGPRBUCHYKV-QXIWCURZSA-N 0.000 claims 1
- UVEBSTGEJQICGK-USEFPYCQSA-N n-[2-[[(3r)-1-[4-hydroxy-4-(6-methoxypyridin-2-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound COC1=CC=CC(C2(O)CCC(CC2)N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)=N1 UVEBSTGEJQICGK-USEFPYCQSA-N 0.000 claims 1
- NXZNYBUBXWWKCP-JMOWIOHXSA-N n-[2-[[(3r)-1-[4-hydroxy-4-(6-methoxypyridin-3-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound C1=NC(OC)=CC=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 NXZNYBUBXWWKCP-JMOWIOHXSA-N 0.000 claims 1
- IDOWXFKHSJBRPE-JMOWIOHXSA-N n-[2-[[(3r)-1-[4-hydroxy-4-(6-methylpyridin-2-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound CC1=CC=CC(C2(O)CCC(CC2)N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)=N1 IDOWXFKHSJBRPE-JMOWIOHXSA-N 0.000 claims 1
- QNNKTOHXHCUXSE-QXIWCURZSA-N n-[2-[[(3r)-1-[4-hydroxy-4-(6-morpholin-4-ylpyridin-3-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=NC(=CC=1)N1CCOCC1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 QNNKTOHXHCUXSE-QXIWCURZSA-N 0.000 claims 1
- VRAVLBVQFTVJPP-DCWSAZFOSA-N n-[2-[[(3r)-1-[4-hydroxy-4-(6-phenylpyridin-3-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=NC(=CC=1)C=1C=CC=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 VRAVLBVQFTVJPP-DCWSAZFOSA-N 0.000 claims 1
- SBWPRUZWQKMGCN-JNDNBTNTSA-N n-[2-[[(3r)-1-[4-hydroxy-4-[2-(methoxymethyl)-1,3-thiazol-5-yl]cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound S1C(COC)=NC=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 SBWPRUZWQKMGCN-JNDNBTNTSA-N 0.000 claims 1
- MSOQAGXSKWVYEV-VEODAXLASA-N n-[2-[[(3r)-1-[4-hydroxy-4-[2-(pyrrolidin-1-ylmethyl)-1,3-thiazol-5-yl]cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1SC(CN2CCCC2)=NC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 MSOQAGXSKWVYEV-VEODAXLASA-N 0.000 claims 1
- PDIBNIHPPUYIKN-QXIWCURZSA-N n-[2-[[(3r)-1-[4-hydroxy-4-[4-(1,3-thiazol-2-yl)phenyl]cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=CC(=CC=1)C=1SC=CN=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 PDIBNIHPPUYIKN-QXIWCURZSA-N 0.000 claims 1
- FNUTXWQFNSMLSG-YAAXVGMDSA-N n-[2-[[(3r)-1-[4-hydroxy-4-[4-(1h-pyrazol-4-yl)phenyl]cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=CC(=CC=1)C1=CNN=C1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 FNUTXWQFNSMLSG-YAAXVGMDSA-N 0.000 claims 1
- KZTGVVAZIZGGMK-MNEVETPYSA-N n-[2-[[(3r)-1-[4-hydroxy-4-[4-(methoxymethyl)phenyl]cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound C1=CC(COC)=CC=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 KZTGVVAZIZGGMK-MNEVETPYSA-N 0.000 claims 1
- ROZPNFLZEKLKKH-VEODAXLASA-N n-[2-[[(3r)-1-[4-hydroxy-4-[5-(1,3-oxazol-2-yl)pyridin-2-yl]cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1N=CC(=CC=1)C=1OC=CN=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 ROZPNFLZEKLKKH-VEODAXLASA-N 0.000 claims 1
- XZYZOVOAHIMREO-VEODAXLASA-N n-[2-[[(3r)-1-[4-hydroxy-4-[5-(1,3-thiazol-2-yl)pyridin-2-yl]cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1N=CC(=CC=1)C=1SC=CN=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 XZYZOVOAHIMREO-VEODAXLASA-N 0.000 claims 1
- WBAMCCHLVRNYDI-WXFIPNSDSA-N n-[2-[[(3r)-1-[4-hydroxy-4-[5-(1h-pyrazol-4-yl)pyridin-2-yl]cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1N=CC(=CC=1)C1=CNN=C1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 WBAMCCHLVRNYDI-WXFIPNSDSA-N 0.000 claims 1
- UNVHCLFXCZTUCW-ANTXIRGESA-N n-[2-[[(3r)-1-[4-hydroxy-4-[5-(3-methoxyphenyl)pyridin-2-yl]cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound COC1=CC=CC(C=2C=NC(=CC=2)C2(O)CCC(CC2)N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)=C1 UNVHCLFXCZTUCW-ANTXIRGESA-N 0.000 claims 1
- PIHORZGMLFKCGG-ANTXIRGESA-N n-[2-[[(3r)-1-[4-hydroxy-4-[5-(4-methoxyphenyl)pyridin-2-yl]cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound C1=CC(OC)=CC=C1C1=CC=C(C2(O)CCC(CC2)N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)N=C1 PIHORZGMLFKCGG-ANTXIRGESA-N 0.000 claims 1
- VFBFHJIJABPGMT-ANTXIRGESA-N n-[2-[[(3r)-1-[4-hydroxy-4-[5-[2-(hydroxymethyl)phenyl]pyridin-2-yl]cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound OCC1=CC=CC=C1C1=CC=C(C2(O)CCC(CC2)N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)N=C1 VFBFHJIJABPGMT-ANTXIRGESA-N 0.000 claims 1
- SPINUELFJQLLLQ-DCWSAZFOSA-N n-[2-[[(3r)-1-[4-hydroxy-4-[5-[4-(trifluoromethyl)phenyl]pyridin-2-yl]cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1N=CC(=CC=1)C=1C=CC(=CC=1)C(F)(F)F)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 SPINUELFJQLLLQ-DCWSAZFOSA-N 0.000 claims 1
- YIYKLPPJNGZYFH-VEODAXLASA-N n-[2-[[(3r)-1-[4-hydroxy-4-[6-(1,3-oxazol-2-yl)pyridin-3-yl]cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=NC(=CC=1)C=1OC=CN=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 YIYKLPPJNGZYFH-VEODAXLASA-N 0.000 claims 1
- JENXGAAEWOFAKP-VEODAXLASA-N n-[2-[[(3r)-1-[4-hydroxy-4-[6-(1,3-thiazol-2-yl)pyridin-3-yl]cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=NC(=CC=1)C=1SC=CN=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 JENXGAAEWOFAKP-VEODAXLASA-N 0.000 claims 1
- ZENSIIADVLWRKG-JMOWIOHXSA-N n-[2-[[(3r)-1-[4-hydroxy-4-[6-(2,2,2-trifluoroethoxy)pyridin-3-yl]cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@@H]1CCN(C1)C1CCC(CC1)(O)C=1C=NC(OCC(F)(F)F)=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 ZENSIIADVLWRKG-JMOWIOHXSA-N 0.000 claims 1
- HNTRFLLOZLDKQV-ZHYGNVHVSA-N n-[2-[[(3r,5s)-1-(4-hydroxy-4-phenylcyclohexyl)-5-methylpyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound C([C@@H](C[C@@H]1C)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)N1C(CC1)CCC1(O)C1=CC=CC=C1 HNTRFLLOZLDKQV-ZHYGNVHVSA-N 0.000 claims 1
- RYYGPYJSKUQZGE-BZIPVCSVSA-N n-[2-[[(3r,5s)-1-(4-hydroxy-4-pyridin-2-ylcyclohexyl)-5-methylpyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound C([C@@H](C[C@@H]1C)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)N1C(CC1)CCC1(O)C1=CC=CC=N1 RYYGPYJSKUQZGE-BZIPVCSVSA-N 0.000 claims 1
- CFWHTAPFHZDCCS-DDKHHDTNSA-N n-[2-[[(3r,5s)-1-(4-hydroxy-4-pyridin-3-ylcyclohexyl)-5-methylpyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound C([C@@H](C[C@@H]1C)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)N1C(CC1)CCC1(O)C1=CC=CN=C1 CFWHTAPFHZDCCS-DDKHHDTNSA-N 0.000 claims 1
- PBNFXMCZRJHVBL-DDKHHDTNSA-N n-[2-[[(3r,5s)-1-(4-hydroxy-4-pyridin-4-ylcyclohexyl)-5-methylpyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound C([C@@H](C[C@@H]1C)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)N1C(CC1)CCC1(O)C1=CC=NC=C1 PBNFXMCZRJHVBL-DDKHHDTNSA-N 0.000 claims 1
- FMPJOKHKDFTXPN-YXXMQHFLSA-N n-[2-[[(3r,5s)-1-[4-hydroxy-4-(4-methylphenyl)cyclohexyl]-5-methylpyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound C([C@@H](C[C@@H]1C)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)N1C(CC1)CCC1(O)C1=CC=C(C)C=C1 FMPJOKHKDFTXPN-YXXMQHFLSA-N 0.000 claims 1
- ARUQTHKMANHWRG-CWXVSUMLSA-N n-[2-[[(3r,5s)-1-[4-hydroxy-4-(5-methylpyridin-2-yl)cyclohexyl]-5-methylpyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound C([C@@H](C[C@@H]1C)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)N1C(CC1)CCC1(O)C1=CC=C(C)C=N1 ARUQTHKMANHWRG-CWXVSUMLSA-N 0.000 claims 1
- YEQNCJGWMSISJU-ZHYGNVHVSA-N n-[2-[[(3r,5s)-1-[4-hydroxy-4-(6-methylpyridin-3-yl)cyclohexyl]-5-methylpyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound C([C@@H](C[C@@H]1C)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)N1C(CC1)CCC1(O)C1=CC=C(C)N=C1 YEQNCJGWMSISJU-ZHYGNVHVSA-N 0.000 claims 1
- MOGZKELVHMJQEA-ZQFKLAOWSA-N n-[2-[[(3s,4s)-1-(4-cyano-4-phenylcyclohexyl)-4-hydroxypyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1O)C1CCC(CC1)(C#N)C=1C=CC=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 MOGZKELVHMJQEA-ZQFKLAOWSA-N 0.000 claims 1
- DSWUOWQLLSQGNU-IOXNAGQWSA-N n-[2-[[(3s,4s)-1-(4-hydroxy-4-phenylcyclohexyl)-4-propoxypyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1OCCC)C1CCC(O)(CC1)C=1C=CC=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 DSWUOWQLLSQGNU-IOXNAGQWSA-N 0.000 claims 1
- NIMLRDUIDRVIOQ-NFJKTXFASA-N n-[2-[[(3s,4s)-1-[4-(3-bromophenyl)-4-hydroxycyclohexyl]-4-hydroxypyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1O)C1CCC(O)(CC1)C=1C=C(Br)C=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 NIMLRDUIDRVIOQ-NFJKTXFASA-N 0.000 claims 1
- WJIICFHBHHVWDM-NFJKTXFASA-N n-[2-[[(3s,4s)-1-[4-(3-chlorophenyl)-4-hydroxycyclohexyl]-4-hydroxypyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1O)C1CCC(O)(CC1)C=1C=C(Cl)C=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 WJIICFHBHHVWDM-NFJKTXFASA-N 0.000 claims 1
- RSSMALCEIZPLRP-PCBKEIHFSA-N n-[2-[[(3s,4s)-1-[4-(3-chlorophenyl)cyclohexyl]-4-hydroxypyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1O)C1CCC(CC1)C=1C=C(Cl)C=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 RSSMALCEIZPLRP-PCBKEIHFSA-N 0.000 claims 1
- NJSMDCPNBRPHID-NFJKTXFASA-N n-[2-[[(3s,4s)-1-[4-(4-bromophenyl)-4-hydroxycyclohexyl]-4-hydroxypyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1O)C1CCC(O)(CC1)C=1C=CC(Br)=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 NJSMDCPNBRPHID-NFJKTXFASA-N 0.000 claims 1
- IJKYMTUCXROEIP-NFJKTXFASA-N n-[2-[[(3s,4s)-1-[4-(4-chlorophenyl)-4-hydroxycyclohexyl]-4-hydroxypyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1O)C1CCC(O)(CC1)C=1C=CC(Cl)=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 IJKYMTUCXROEIP-NFJKTXFASA-N 0.000 claims 1
- DOONTHIITIMJQC-XRYVGEESSA-N n-[2-[[(3s,4s)-1-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxypyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1O)C1CCC(CC1)C=1C=CC(Cl)=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 DOONTHIITIMJQC-XRYVGEESSA-N 0.000 claims 1
- SPSCXYMYTNTMPU-UBFBPUDLSA-N n-[2-[[(3s,4s)-1-[4-(6-ethoxypyridin-3-yl)-4-hydroxycyclohexyl]-4-hydroxypyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound C1=NC(OCC)=CC=C1C1(O)CCC(N2C[C@@H]([C@@H](O)C2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 SPSCXYMYTNTMPU-UBFBPUDLSA-N 0.000 claims 1
- RCUMNFOFNDIQIF-XOTWMYLBSA-N n-[2-[[(3s,4s)-1-[4-hydroxy-4-(4-methoxyphenyl)cyclohexyl]-4-propoxypyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1OCCC)C1CCC(O)(CC1)C=1C=CC(OC)=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 RCUMNFOFNDIQIF-XOTWMYLBSA-N 0.000 claims 1
- ZZTHSVRCXTVHFO-BAWWGMJKSA-N n-[2-[[(3s,4s)-1-[4-hydroxy-4-(4-methylpyridin-2-yl)cyclohexyl]-4-propoxypyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1OCCC)C1CCC(O)(CC1)C=1N=CC=C(C)C=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 ZZTHSVRCXTVHFO-BAWWGMJKSA-N 0.000 claims 1
- WJJGUXZZYGYXHK-BAWWGMJKSA-N n-[2-[[(3s,4s)-1-[4-hydroxy-4-(5-methylpyridin-2-yl)cyclohexyl]-4-propoxypyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1OCCC)C1CCC(O)(CC1)C=1N=CC(C)=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 WJJGUXZZYGYXHK-BAWWGMJKSA-N 0.000 claims 1
- IBCIWAJWDTXVQF-BYQSVQIVSA-N n-[2-[[(3s,4s)-1-[4-hydroxy-4-(6-methoxypyridin-2-yl)cyclohexyl]-4-propoxypyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1OCCC)C1CCC(O)(CC1)C=1N=C(OC)C=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 IBCIWAJWDTXVQF-BYQSVQIVSA-N 0.000 claims 1
- OBJMHLSHLUXFKU-BAWWGMJKSA-N n-[2-[[(3s,4s)-1-[4-hydroxy-4-(6-methoxypyridin-3-yl)cyclohexyl]-4-propoxypyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1OCCC)C1CCC(O)(CC1)C=1C=NC(OC)=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 OBJMHLSHLUXFKU-BAWWGMJKSA-N 0.000 claims 1
- FIWGLURXQQWFMV-BAWWGMJKSA-N n-[2-[[(3s,4s)-1-[4-hydroxy-4-(6-methylpyridin-2-yl)cyclohexyl]-4-propoxypyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1OCCC)C1CCC(O)(CC1)C=1N=C(C)C=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 FIWGLURXQQWFMV-BAWWGMJKSA-N 0.000 claims 1
- BUPXXNZCSAFGJW-GOTSBHOMSA-N n-[2-[[(3s,4s)-1-cyclohexyl-4-(pyridin-2-ylmethoxy)pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound FC(F)(F)C1=CC=CC(C(=O)NCC(=O)N[C@@H]2[C@H](CN(C2)C2CCCCC2)OCC=2N=CC=CC=2)=C1 BUPXXNZCSAFGJW-GOTSBHOMSA-N 0.000 claims 1
- RQHCXVKNDMXMHM-GOTSBHOMSA-N n-[2-[[(3s,4s)-1-cyclohexyl-4-(pyridin-3-ylmethoxy)pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound FC(F)(F)C1=CC=CC(C(=O)NCC(=O)N[C@@H]2[C@H](CN(C2)C2CCCCC2)OCC=2C=NC=CC=2)=C1 RQHCXVKNDMXMHM-GOTSBHOMSA-N 0.000 claims 1
- YDYMBWBMCHCIGW-IRXDYDNUSA-N n-[2-[[(3s,4s)-1-cyclohexyl-4-hydroxypyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1O)C1CCCCC1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 YDYMBWBMCHCIGW-IRXDYDNUSA-N 0.000 claims 1
- VGTKGBXYMBWRLP-ZEQRLZLVSA-N n-[2-[[(3s,4s)-1-cyclohexyl-4-phenylmethoxypyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound FC(F)(F)C1=CC=CC(C(=O)NCC(=O)N[C@@H]2[C@H](CN(C2)C2CCCCC2)OCC=2C=CC=CC=2)=C1 VGTKGBXYMBWRLP-ZEQRLZLVSA-N 0.000 claims 1
- KLHQJQIPLYZOOT-ZCOIRKDISA-N n-[2-[[(3s,4s)-4-ethoxy-1-(4-hydroxy-4-phenylcyclohexyl)pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1OCC)C1CCC(O)(CC1)C=1C=CC=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 KLHQJQIPLYZOOT-ZCOIRKDISA-N 0.000 claims 1
- NDZQBPKMKRMDQZ-DVZTWYNPSA-N n-[2-[[(3s,4s)-4-ethoxy-1-(4-pyridin-2-ylcyclohexyl)pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1OCC)C1CCC(CC1)C=1N=CC=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 NDZQBPKMKRMDQZ-DVZTWYNPSA-N 0.000 claims 1
- ZUVYVAATEZDRLD-FLLKZOGESA-N n-[2-[[(3s,4s)-4-ethoxy-1-(4-pyridin-3-ylcyclohexyl)pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1OCC)C1CCC(CC1)C=1C=NC=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 ZUVYVAATEZDRLD-FLLKZOGESA-N 0.000 claims 1
- XZOMZWVLAHXPKB-FLLKZOGESA-N n-[2-[[(3s,4s)-4-ethoxy-1-(4-pyridin-4-ylcyclohexyl)pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1OCC)C1CCC(CC1)C=1C=CN=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 XZOMZWVLAHXPKB-FLLKZOGESA-N 0.000 claims 1
- LQLMQWXIQQJGGS-ZCOIRKDISA-N n-[2-[[(3s,4s)-4-ethoxy-1-[4-(3-fluorophenyl)-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1OCC)C1CCC(O)(CC1)C=1C=C(F)C=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 LQLMQWXIQQJGGS-ZCOIRKDISA-N 0.000 claims 1
- PHOLEOTXENIUDW-ZCOIRKDISA-N n-[2-[[(3s,4s)-4-ethoxy-1-[4-(4-fluorophenyl)-4-hydroxycyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1OCC)C1CCC(O)(CC1)C=1C=CC(F)=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 PHOLEOTXENIUDW-ZCOIRKDISA-N 0.000 claims 1
- UVIJCDZUVXDUOK-MDZVREACSA-N n-[2-[[(3s,4s)-4-ethoxy-1-[4-hydroxy-4-(3-methoxyphenyl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1OCC)C1CCC(O)(CC1)C=1C=C(OC)C=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 UVIJCDZUVXDUOK-MDZVREACSA-N 0.000 claims 1
- RNNAMHZABORLIG-MDZVREACSA-N n-[2-[[(3s,4s)-4-ethoxy-1-[4-hydroxy-4-(4-methoxyphenyl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1OCC)C1CCC(O)(CC1)C=1C=CC(OC)=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 RNNAMHZABORLIG-MDZVREACSA-N 0.000 claims 1
- JQPQRYDIQFLFAA-IOXNAGQWSA-N n-[2-[[(3s,4s)-4-ethoxy-1-[4-hydroxy-4-(4-methylphenyl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1OCC)C1CCC(O)(CC1)C=1C=CC(C)=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 JQPQRYDIQFLFAA-IOXNAGQWSA-N 0.000 claims 1
- GUZJEYVPUMKKLK-YKUCYRFJSA-N n-[2-[[(3s,4s)-4-ethoxy-1-[4-hydroxy-4-(4-methylpyridin-2-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1OCC)C1CCC(O)(CC1)C=1N=CC=C(C)C=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 GUZJEYVPUMKKLK-YKUCYRFJSA-N 0.000 claims 1
- DDGUFECXDQKCFJ-YKUCYRFJSA-N n-[2-[[(3s,4s)-4-ethoxy-1-[4-hydroxy-4-(5-methylpyridin-2-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1OCC)C1CCC(O)(CC1)C=1N=CC(C)=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 DDGUFECXDQKCFJ-YKUCYRFJSA-N 0.000 claims 1
- PSFQENFUGCSXKE-YKUCYRFJSA-N n-[2-[[(3s,4s)-4-ethoxy-1-[4-hydroxy-4-(6-methylpyridin-2-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1OCC)C1CCC(O)(CC1)C=1N=C(C)C=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 PSFQENFUGCSXKE-YKUCYRFJSA-N 0.000 claims 1
- MZIHXQCZYGZXOH-NFJKTXFASA-N n-[2-[[(3s,4s)-4-hydroxy-1-(4-hydroxy-4-phenylcyclohexyl)pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1O)C1CCC(O)(CC1)C=1C=CC=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 MZIHXQCZYGZXOH-NFJKTXFASA-N 0.000 claims 1
- NMPCTCVVSBDEDE-ZRDDSIGQSA-N n-[2-[[(3s,4s)-4-hydroxy-1-(4-hydroxy-4-pyridin-3-ylcyclohexyl)pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1O)C1CCC(O)(CC1)C=1C=NC=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 NMPCTCVVSBDEDE-ZRDDSIGQSA-N 0.000 claims 1
- JJCWAJUSLUVWGF-ZRDDSIGQSA-N n-[2-[[(3s,4s)-4-hydroxy-1-(4-hydroxy-4-pyridin-4-ylcyclohexyl)pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1O)C1CCC(O)(CC1)C=1C=CN=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 JJCWAJUSLUVWGF-ZRDDSIGQSA-N 0.000 claims 1
- FIFCGZJWFIFLMF-ZNJKDYDLSA-N n-[2-[[(3s,4s)-4-hydroxy-1-(4-pyridin-2-ylcyclohexyl)pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1O)C1CCC(CC1)C=1N=CC=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 FIFCGZJWFIFLMF-ZNJKDYDLSA-N 0.000 claims 1
- VFTXVOYPRBTANV-KUCMRCCESA-N n-[2-[[(3s,4s)-4-hydroxy-1-[4-(5-methylpyridin-2-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N1=CC(C)=CC=C1C1CCC(N2C[C@@H]([C@@H](O)C2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 VFTXVOYPRBTANV-KUCMRCCESA-N 0.000 claims 1
- GRWLRFHBSLLKJE-KUCMRCCESA-N n-[2-[[(3s,4s)-4-hydroxy-1-[4-(6-methylpyridin-2-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound CC1=CC=CC(C2CCC(CC2)N2C[C@@H]([C@@H](O)C2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)=N1 GRWLRFHBSLLKJE-KUCMRCCESA-N 0.000 claims 1
- NPQBJJTUZQXVBT-OGTWAPGSSA-N n-[2-[[(3s,4s)-4-hydroxy-1-[4-hydroxy-4-(2-methoxyphenyl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound COC1=CC=CC=C1C1(O)CCC(N2C[C@@H]([C@@H](O)C2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 NPQBJJTUZQXVBT-OGTWAPGSSA-N 0.000 claims 1
- HJRUZHCGOZFWIA-BZYPPAADSA-N n-[2-[[(3s,4s)-4-hydroxy-1-[4-hydroxy-4-(2-methylphenyl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound CC1=CC=CC=C1C1(O)CCC(N2C[C@@H]([C@@H](O)C2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 HJRUZHCGOZFWIA-BZYPPAADSA-N 0.000 claims 1
- NPKKWAIFVDJXDS-BZYPPAADSA-N n-[2-[[(3s,4s)-4-hydroxy-1-[4-hydroxy-4-(3-methoxyphenyl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound COC1=CC=CC(C2(O)CCC(CC2)N2C[C@@H]([C@@H](O)C2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)=C1 NPKKWAIFVDJXDS-BZYPPAADSA-N 0.000 claims 1
- WMTWNGATLVZCJO-ZQFKLAOWSA-N n-[2-[[(3s,4s)-4-hydroxy-1-[4-hydroxy-4-(3-methylphenyl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound CC1=CC=CC(C2(O)CCC(CC2)N2C[C@@H]([C@@H](O)C2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)=C1 WMTWNGATLVZCJO-ZQFKLAOWSA-N 0.000 claims 1
- MTSGMIOGZFKXKS-BZYPPAADSA-N n-[2-[[(3s,4s)-4-hydroxy-1-[4-hydroxy-4-(4-methoxyphenyl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound C1=CC(OC)=CC=C1C1(O)CCC(N2C[C@@H]([C@@H](O)C2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 MTSGMIOGZFKXKS-BZYPPAADSA-N 0.000 claims 1
- XHGVBJNSDZIZLM-ZQFKLAOWSA-N n-[2-[[(3s,4s)-4-hydroxy-1-[4-hydroxy-4-(4-methylphenyl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound C1=CC(C)=CC=C1C1(O)CCC(N2C[C@@H]([C@@H](O)C2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 XHGVBJNSDZIZLM-ZQFKLAOWSA-N 0.000 claims 1
- OUQTVCJXCWFIJC-YSYGYCFTSA-N n-[2-[[(9s)-7-(4-hydroxy-4-phenylcyclohexyl)-1-oxa-7-azaspiro[4.4]nonan-9-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(CC11OCCC1)C1CCC(CC1)(O)C=1C=CC=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 OUQTVCJXCWFIJC-YSYGYCFTSA-N 0.000 claims 1
- UWQSSWJGMTYGDT-UHFFFAOYSA-N n-[2-[[3-(fluoromethyl)-1-(4-hydroxy-4-phenylcyclohexyl)pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide Chemical compound C1CC(O)(C=2C=CC=CC=2)CCC1N(C1)CCC1(CF)NC(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 UWQSSWJGMTYGDT-UHFFFAOYSA-N 0.000 claims 1
- AILUUVYEEYSXLA-HVIUMASTSA-N n-[2-oxo-2-[[(3r)-1-(4-phenoxycyclohexyl)pyrrolidin-3-yl]amino]ethyl]-3-(trifluoromethyl)benzamide Chemical compound FC(F)(F)C1=CC=CC(C(=O)NCC(=O)N[C@H]2CN(CC2)C2CCC(CC2)OC=2C=CC=CC=2)=C1 AILUUVYEEYSXLA-HVIUMASTSA-N 0.000 claims 1
- AAOYFRVMYXIGFD-TWMPVWRBSA-N n-[2-oxo-2-[[(3r)-1-(4-pyridin-2-ylcyclohexyl)pyrrolidin-3-yl]amino]ethyl]-3-(trifluoromethyl)benzamide Chemical compound FC(F)(F)C1=CC=CC(C(=O)NCC(=O)N[C@H]2CN(CC2)C2CCC(CC2)C=2N=CC=CC=2)=C1 AAOYFRVMYXIGFD-TWMPVWRBSA-N 0.000 claims 1
- PYWSAWVTQQXEJA-PDRFFQIWSA-N n-[2-oxo-2-[[(3r)-1-(4-pyridin-3-ylcyclohexyl)pyrrolidin-3-yl]amino]ethyl]-3-(trifluoromethyl)benzamide Chemical compound FC(F)(F)C1=CC=CC(C(=O)NCC(=O)N[C@H]2CN(CC2)C2CCC(CC2)C=2C=NC=CC=2)=C1 PYWSAWVTQQXEJA-PDRFFQIWSA-N 0.000 claims 1
- DJYNOSREKOEFMN-PDRFFQIWSA-N n-[2-oxo-2-[[(3r)-1-(4-pyridin-4-ylcyclohexyl)pyrrolidin-3-yl]amino]ethyl]-3-(trifluoromethyl)benzamide Chemical compound FC(F)(F)C1=CC=CC(C(=O)NCC(=O)N[C@H]2CN(CC2)C2CCC(CC2)C=2C=CN=CC=2)=C1 DJYNOSREKOEFMN-PDRFFQIWSA-N 0.000 claims 1
- XMYCKOVAGBTIPW-WXFUMESZSA-N n-[2-oxo-2-[[(3r)-1-[(1r,2r)-2-phenylmethoxycyclohexyl]pyrrolidin-3-yl]amino]ethyl]-3-(trifluoromethyl)benzamide Chemical compound FC(F)(F)C1=CC=CC(C(=O)NCC(=O)N[C@H]2CN(CC2)[C@H]2[C@@H](CCCC2)OCC=2C=CC=CC=2)=C1 XMYCKOVAGBTIPW-WXFUMESZSA-N 0.000 claims 1
- YLNKWAOODGCNHT-WTUOKKPGSA-N n-[2-oxo-2-[[(3s,4s)-4-propoxy-1-(4-pyridin-3-ylcyclohexyl)pyrrolidin-3-yl]amino]ethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1OCCC)C1CCC(CC1)C=1C=NC=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 YLNKWAOODGCNHT-WTUOKKPGSA-N 0.000 claims 1
- FEFXPONLJKQWEC-WTUOKKPGSA-N n-[2-oxo-2-[[(3s,4s)-4-propoxy-1-(4-pyridin-4-ylcyclohexyl)pyrrolidin-3-yl]amino]ethyl]-3-(trifluoromethyl)benzamide Chemical compound N([C@H]1CN(C[C@@H]1OCCC)C1CCC(CC1)C=1C=CN=CC=1)C(=O)CNC(=O)C1=CC=CC(C(F)(F)F)=C1 FEFXPONLJKQWEC-WTUOKKPGSA-N 0.000 claims 1
- MIXVCDZGACMOGR-NYLDSWQDSA-N n-[4-[(3r)-3-[[2-[[3-(trifluoromethyl)benzoyl]amino]acetyl]amino]pyrrolidin-1-yl]cyclohexyl]pyridine-2-carboxamide Chemical compound FC(F)(F)C1=CC=CC(C(=O)NCC(=O)N[C@H]2CN(CC2)C2CCC(CC2)NC(=O)C=2N=CC=CC=2)=C1 MIXVCDZGACMOGR-NYLDSWQDSA-N 0.000 claims 1
- DXWSOQGJQGDZPJ-ATKRNPRHSA-N n-[4-[(3r)-3-[[2-[[3-(trifluoromethyl)benzoyl]amino]acetyl]amino]pyrrolidin-1-yl]cyclohexyl]pyridine-3-carboxamide Chemical compound FC(F)(F)C1=CC=CC(C(=O)NCC(=O)N[C@H]2CN(CC2)C2CCC(CC2)NC(=O)C=2C=NC=CC=2)=C1 DXWSOQGJQGDZPJ-ATKRNPRHSA-N 0.000 claims 1
- CCWIRBJJFODGHO-ATKRNPRHSA-N n-[4-[(3r)-3-[[2-[[3-(trifluoromethyl)benzoyl]amino]acetyl]amino]pyrrolidin-1-yl]cyclohexyl]pyridine-4-carboxamide Chemical compound FC(F)(F)C1=CC=CC(C(=O)NCC(=O)N[C@H]2CN(CC2)C2CCC(CC2)NC(=O)C=2C=CN=CC=2)=C1 CCWIRBJJFODGHO-ATKRNPRHSA-N 0.000 claims 1
- AIFAXMFFYULXLO-OOMBGRCJSA-N n-[4-[(3r)-3-[[2-[[3-(trifluoromethyl)benzoyl]amino]acetyl]amino]pyrrolidin-1-yl]cyclohexyl]quinoline-4-carboxamide Chemical compound FC(F)(F)C1=CC=CC(C(=O)NCC(=O)N[C@H]2CN(CC2)C2CCC(CC2)NC(=O)C=2C3=CC=CC=C3N=CC=2)=C1 AIFAXMFFYULXLO-OOMBGRCJSA-N 0.000 claims 1
- BIUFSSRQRZICKR-VLNJMECTSA-N n-ethyl-2-[1-hydroxy-4-[(3r)-3-[[2-[[3-(trifluoromethyl)benzoyl]amino]acetyl]amino]pyrrolidin-1-yl]cyclohexyl]-1,3-thiazole-5-carboxamide Chemical compound S1C(C(=O)NCC)=CN=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 BIUFSSRQRZICKR-VLNJMECTSA-N 0.000 claims 1
- JVEQSFCDEUBODG-VLNJMECTSA-N n-ethyl-5-[1-hydroxy-4-[(3r)-3-[[2-[[3-(trifluoromethyl)benzoyl]amino]acetyl]amino]pyrrolidin-1-yl]cyclohexyl]-1,3-thiazole-2-carboxamide Chemical compound S1C(C(=O)NCC)=NC=C1C1(O)CCC(N2C[C@@H](CC2)NC(=O)CNC(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 JVEQSFCDEUBODG-VLNJMECTSA-N 0.000 claims 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical group C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 claims 1
- 208000004296 neuralgia Diseases 0.000 claims 1
- 208000021722 neuropathic pain Diseases 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 claims 1
- 208000037803 restenosis Diseases 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42960502P | 2002-11-27 | 2002-11-27 | |
| US60/429,605 | 2002-11-27 | ||
| US46397603P | 2003-04-18 | 2003-04-18 | |
| US60/463,976 | 2003-04-18 | ||
| PCT/US2003/037946 WO2004050024A2 (en) | 2002-11-27 | 2003-11-26 | 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011160080A Division JP2011251987A (ja) | 2002-11-27 | 2011-07-21 | ケモカイン受容体のモジュレーターとしての３−アミノピロリジン誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006516145A JP2006516145A (ja) | 2006-06-22 |
| JP2006516145A5 true JP2006516145A5 (https=) | 2007-01-18 |
| JP4828829B2 JP4828829B2 (ja) | 2011-11-30 |
Family
ID=32474514
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004570963A Expired - Lifetime JP4828829B2 (ja) | 2002-11-27 | 2003-11-26 | ケモカイン受容体のモジュレーターとしての３−アミノピロリジン誘導体 |
| JP2011160080A Pending JP2011251987A (ja) | 2002-11-27 | 2011-07-21 | ケモカイン受容体のモジュレーターとしての３−アミノピロリジン誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011160080A Pending JP2011251987A (ja) | 2002-11-27 | 2011-07-21 | ケモカイン受容体のモジュレーターとしての３−アミノピロリジン誘導体 |
Country Status (26)
| Country | Link |
|---|---|
| US (4) | US7834021B2 (https=) |
| EP (2) | EP1565436B1 (https=) |
| JP (2) | JP4828829B2 (https=) |
| KR (1) | KR100895968B1 (https=) |
| CN (1) | CN102153539B (https=) |
| AT (1) | ATE555087T1 (https=) |
| AU (1) | AU2003293129B2 (https=) |
| BR (1) | BRPI0316732B8 (https=) |
| CA (1) | CA2507501C (https=) |
| CO (1) | CO5690550A2 (https=) |
| CR (2) | CR7846A (https=) |
| EA (1) | EA010027B1 (https=) |
| EC (1) | ECSP055856A (https=) |
| ES (1) | ES2383296T3 (https=) |
| GE (1) | GEP20115290B (https=) |
| HU (1) | HU230612B1 (https=) |
| IL (1) | IL168742A (https=) |
| IS (1) | IS2892B (https=) |
| MX (1) | MXPA05005660A (https=) |
| NO (1) | NO330860B1 (https=) |
| NZ (1) | NZ540290A (https=) |
| PL (1) | PL376925A1 (https=) |
| RU (1) | RU2355679C2 (https=) |
| SE (1) | SE529361C2 (https=) |
| SG (1) | SG173922A1 (https=) |
| WO (1) | WO2004050024A2 (https=) |
Families Citing this family (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0202133D0 (sv) * | 2002-07-08 | 2002-07-08 | Astrazeneca Ab | Novel compounds |
| EP1565436B1 (en) * | 2002-11-27 | 2012-04-25 | Incyte Corporation | 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| US7378409B2 (en) | 2003-08-21 | 2008-05-27 | Bristol-Myers Squibb Company | Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity |
| US20070021498A1 (en) * | 2004-10-14 | 2007-01-25 | Nafizal Hossain | Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
| SE0302755D0 (sv) * | 2003-10-17 | 2003-10-17 | Astrazeneca Ab | Novel compounds |
| SE0303090D0 (sv) * | 2003-11-20 | 2003-11-20 | Astrazeneca Ab | Novel compounds |
| KR20080052683A (ko) * | 2003-12-18 | 2008-06-11 | 인사이트 코포레이션 | 케모킨 수용체의 조절제로서의3-사이클로알킬아미노피롤리딘 유도체 |
| SE0303541D0 (sv) | 2003-12-22 | 2003-12-22 | Astrazeneca Ab | New compounds |
| EA015517B1 (ru) * | 2004-04-13 | 2011-08-30 | Инсайт Корпорейшн | Производные пиперазинилпиперидина в качестве антагонистов хемокинового рецептора |
| BRPI0510665A (pt) | 2004-05-11 | 2007-12-04 | Incyte Corp | 3-(4-heteroarilcicloexilamino) ciclopentano-carboxiamidas como moduladores de receptores de quimiocinas |
| CN1329374C (zh) * | 2004-06-09 | 2007-08-01 | 上海靶点药物有限公司 | 作为ccr5拮抗剂的化合物 |
| WO2006004741A2 (en) | 2004-06-28 | 2006-01-12 | Incyte Corporation | 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| MXPA06014672A (es) | 2004-06-28 | 2007-03-26 | Incyte Corp | 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas. |
| GB0417801D0 (en) * | 2004-08-10 | 2004-09-15 | Novartis Ag | Organic compounds |
| PA8653301A1 (es) * | 2004-11-22 | 2006-11-09 | Incyte Corp Incyte Corp | Sales de la n-[2-({(3r)-1-[trans-4-hidroxi-4-(6-metoxipiridin-3-il) ciclohexil)pirrolidin |
| US7906645B2 (en) | 2004-12-24 | 2011-03-15 | Astrazeneca Ab | Heterocyclic compounds as ccr2b antagonists |
| US8067457B2 (en) | 2005-11-01 | 2011-11-29 | Millennium Pharmaceuticals, Inc. | Compounds useful as antagonists of CCR2 |
| WO2007053499A2 (en) | 2005-11-01 | 2007-05-10 | Millennium Pharmaceuticals, Inc. | Compounds useful as antagonists of ccr2 |
| GB0525957D0 (en) | 2005-12-21 | 2006-02-01 | Astrazeneca Ab | Methods |
| CA2657639A1 (en) * | 2006-07-19 | 2008-01-24 | Astrazeneca Ab | Novel tricyclic spiropiperidine compounds, their synthesis and their uses as modulators of chemokine receptor activity |
| AR063275A1 (es) * | 2006-10-12 | 2009-01-14 | Epix Delaware Inc | Compuestos de carboxamida, una composicion farmaceutica que los comprende y su uso en la preparacion de un medicamento para el tratamiento de enfermedades mediadas por la activacion de ccr2. |
| CN101534824A (zh) | 2006-11-17 | 2009-09-16 | 艾博特公司 | 作为化学活素受体拮抗剂的氨基吡咯烷 |
| CA2674359A1 (en) * | 2006-11-20 | 2008-05-29 | N.V. Organon | Metabolically-stabilized inhibitors of fatty acid amide hydrolase |
| WO2009088504A1 (en) | 2008-01-07 | 2009-07-16 | Vanderbilt University | Solenoid valve assembly |
| US7496166B1 (en) * | 2008-04-29 | 2009-02-24 | International Business Machines Corporation | Dual clock spread for low clock emissions with recovery |
| EP2583556B1 (de) * | 2008-07-17 | 2016-01-20 | Bayer CropScience AG | Heterocyclische Verbindungen als Schädlingsbekämpfungsmittel |
| WO2010011302A1 (en) * | 2008-07-22 | 2010-01-28 | Chdi, Inc. | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| MX2011006226A (es) * | 2008-12-10 | 2011-06-24 | Janssen Pharmaceutica Nv | Antagonistas de 4-azetidinil-1-heteroaril-ciclohexanol del receptor 2 de citocina quimioatrayente. |
| KR101084551B1 (ko) * | 2008-12-26 | 2011-11-17 | 양지화학 주식회사 | Ｃｃｒ2 길항제로서의 3-아미노피롤리딘 유도체 |
| TW201105649A (en) * | 2009-04-16 | 2011-02-16 | Janssen Pharmaceutica Nv | 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of CCR2 |
| CN102459226B (zh) | 2009-04-17 | 2014-09-17 | 詹森药业有限公司 | Ccr2的4-氮杂环丁烷基-1-杂原子连接的-环己烷拮抗剂 |
| EP2419419B1 (en) * | 2009-04-17 | 2014-12-03 | Janssen Pharmaceutica NV | 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2 |
| KR101151415B1 (ko) | 2009-07-10 | 2012-06-01 | 양지화학 주식회사 | Ｃｃｒ２ 길항제로서의 피페라지닐에틸 3-아미노피롤리딘 유도체 |
| TW201211027A (en) * | 2010-06-09 | 2012-03-16 | Janssen Pharmaceutica Nv | Cyclohexyl-azetidinyl antagonists of CCR2 |
| US8518969B2 (en) * | 2010-06-17 | 2013-08-27 | Janssen Pharmaceutica Nv | Cyclohexyl-azetidinyl antagonists of CCR2 |
| KR101318656B1 (ko) | 2010-10-08 | 2013-10-16 | 양지화학 주식회사 | 항천식 활성을 가진 3-아미노피롤리딘 유도체를 포함하는 약학 조성물 |
| EP2685828A4 (en) * | 2011-03-17 | 2014-08-13 | Merck Sharp & Dohme | SUBSTITUTED 3-AZABICYCLO [3,1,0-] HEXAN DERIVATIVES AS CCR2 ANTAGONISTS |
| SI2750677T1 (sl) | 2011-08-30 | 2017-10-30 | Chdi Foundation, Inc. | Inhibitorji kinurenin-3-monooksigenaze, farmacevtski sestavki in postopki njihove uporabe |
| KR20140072037A (ko) | 2011-08-30 | 2014-06-12 | 씨에이치디아이 파운데이션, 인코포레이티드 | 키뉴레닌-3-모노옥시게나제 억제제, 약학적 조성물 및 이의 사용 방법 |
| WO2013047813A1 (ja) | 2011-09-30 | 2013-04-04 | 大鵬薬品工業株式会社 | １，２，４－トリアジン－６－カルボキサミド誘導体 |
| EP2780015B1 (en) | 2011-11-18 | 2017-01-04 | Heptares Therapeutics Limited | Muscarinic m1 receptor agonists |
| WO2013149376A1 (en) | 2012-04-02 | 2013-10-10 | Abbott Laboratories | Chemokine receptor antagonists |
| GB201404922D0 (en) | 2014-03-19 | 2014-04-30 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| AU2015289492B2 (en) | 2014-07-17 | 2020-02-20 | Chdi Foundation, Inc. | Methods and compositions for treating HIV-related disorders |
| GB201513743D0 (en) | 2015-08-03 | 2015-09-16 | Heptares Therapeutics Ltd | Muscarinic agonists |
| RU2606230C1 (ru) * | 2015-10-20 | 2017-01-10 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет" | (Z)-Этил 2-(4-(4-хлорфенил)-2,4-диоксо-3-(3-оксо-3,4-дигидрохиноксалин-2(1Н)-илиден)бутанамидо)-4-метил-5-фенилтиофен-3-карбоксилат, обладающий противодиабетической активностью, и способ его получения |
| GB201519352D0 (en) | 2015-11-02 | 2015-12-16 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| MA45782B1 (fr) | 2016-07-28 | 2021-12-31 | Idorsia Pharmaceuticals Ltd | Modulateurs du récepteur de cxcr7 pipéridine |
| GB201617454D0 (en) | 2016-10-14 | 2016-11-30 | Heptares Therapeutics Limited | Pharmaceutical compounds |
| WO2018106945A1 (en) | 2016-12-07 | 2018-06-14 | Progenity Inc. | Gastrointestinal tract detection methods, devices and systems |
| EP3554541B1 (en) | 2016-12-14 | 2023-06-07 | Biora Therapeutics, Inc. | Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor |
| US11939320B2 (en) | 2017-11-02 | 2024-03-26 | Abbvie Inc. | Modulators of the integrated stress pathway |
| WO2019145460A1 (en) | 2018-01-26 | 2019-08-01 | Idorsia Pharmaceuticals Ltd | Crystalline forms of the cxcr7 receptor antagonist (3s,4s)-1-cyclopropylmethyl-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-3-carboxylic acid (1-pyrimidin-2-yl-cyclopropyl)-amide |
| GB201810239D0 (en) | 2018-06-22 | 2018-08-08 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| EP3883635A1 (en) | 2018-11-19 | 2021-09-29 | Progenity, Inc. | Methods and devices for treating a disease with biotherapeutics |
| GB201819960D0 (en) | 2018-12-07 | 2019-01-23 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201819961D0 (en) | 2018-12-07 | 2019-01-23 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| MA55556A (fr) | 2019-04-02 | 2022-02-09 | Aligos Therapeutics Inc | Composés ciblant prmt5 |
| GB202020191D0 (en) | 2020-12-18 | 2021-02-03 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| CN115666704B (zh) | 2019-12-13 | 2025-09-26 | 比特比德科有限责任公司 | 用于将治疗剂递送至胃肠道的可摄取装置 |
| TWI860849B (zh) | 2021-09-14 | 2024-11-01 | 美商美國禮來大藥廠 | Sstr4促效劑鹽 |
| WO2023081665A1 (en) * | 2021-11-02 | 2023-05-11 | Aria Pharmaceuticals, Inc. | Compounds as crr2 modulators |
| WO2023081662A1 (en) * | 2021-11-02 | 2023-05-11 | Aria Pharmaceuticals, Inc. | Bicyclic derivatives as ccr2 modulators |
| WO2023081666A1 (en) * | 2021-11-02 | 2023-05-11 | Aria Pharmaceuticals, Inc. | Compounds as ccr2 modulators |
| WO2023081661A1 (en) * | 2021-11-02 | 2023-05-11 | Aria Pharmaceuticals, Inc. | Bicyclic derivatives as ccr2 modulators |
| CN119462429B (zh) * | 2024-11-19 | 2025-10-31 | 河北工业大学 | 一种由对甲苯胺合成氨基-甲基-苯氨基甲酸甲酯类化合物的方法 |
Family Cites Families (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US26186A (en) * | 1859-11-22 | Cut-off arrangement for steam-valves | ||
| NO142077C (no) | 1972-04-03 | 1980-06-25 | Robins Co Inc A H | Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-cyclohexyl-3-pyrrolidinyl)-benzamider |
| US4026836A (en) * | 1975-12-29 | 1977-05-31 | Texaco Development Corporation | Isocyanurate foam catalyst |
| HU175454B (hu) * | 1977-07-25 | 1980-08-28 | Chinoin Gyogyszer Es Vegyeszet | Sposob poluchenija novykh predel'nykh i chastichno predel'nykh n-acil-pirrol-2,5-dionov |
| US4333734A (en) * | 1980-01-18 | 1982-06-08 | Sloan-Kettering Institute For Cancer Research | Diagnostic device for fecal occult blood and method of use |
| US4785119A (en) * | 1985-10-11 | 1988-11-15 | Tokyo Kasei Kogyo Co., Ltd. | 3-aminopyrrolidine compound and process for preparation thereof |
| WO1995008533A1 (en) | 1993-09-21 | 1995-03-30 | Yamanouchi Pharmaceutical Co., Ltd. | N-(3-pyrrolidinyl)benzamide derivative |
| PL314191A1 (en) * | 1993-11-02 | 1996-09-02 | Neurobiological Technologies | Method of treating rheumatoid artritis |
| US5770573A (en) * | 1993-12-06 | 1998-06-23 | Cytel Corporation | CS-1 peptidomimetics, compositions and methods of using the same |
| US6686353B1 (en) | 1996-05-20 | 2004-02-03 | Teijin Intellectual Property Center Limited | Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| AU729415B2 (en) | 1996-07-12 | 2001-02-01 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| JP4166296B2 (ja) * | 1997-04-25 | 2008-10-15 | 塩野義製薬株式会社 | ドーパミン受容体拮抗作用を有する化合物 |
| JP2002505684A (ja) * | 1997-06-18 | 2002-02-19 | メルク エンド カンパニー インコーポレーテッド | α１ａアドレナリン受容体拮抗薬 |
| SK285729B6 (sk) * | 1997-11-18 | 2007-07-06 | Teijin Pharma Limited | Zlúčenina derivátov cyklických amínov a jej použitie |
| US6312689B1 (en) | 1998-07-23 | 2001-11-06 | Millennium Pharmaceuticals, Inc. | Anti-CCR2 antibodies and methods of use therefor |
| US6197974B1 (en) | 1998-10-26 | 2001-03-06 | Abbott Laboratories | Enantioselective synthesis of 3-aminopyrrolidines |
| US6468998B1 (en) * | 1998-11-02 | 2002-10-22 | Mitsubishi Pharma Corporation | Pyrrolidine compounds and medicinal utilization thereof |
| US7217714B1 (en) | 1998-12-23 | 2007-05-15 | Agouron Pharmaceuticals, Inc. | CCR5 modulators |
| US6248755B1 (en) | 1999-04-06 | 2001-06-19 | Merck & Co., Inc. | Pyrrolidine modulators of chemokine receptor activity |
| AU4796700A (en) * | 1999-05-13 | 2000-12-05 | Dupont Pharmaceuticals Research Laboratories, Inc. | Ureido-substituted cyclic amine derivatives and their use as drug |
| CA2373942A1 (en) | 1999-05-18 | 2000-11-23 | Teijin Limited | Remedies or prophylactis for diseases in association with chemokines |
| RU2144397C1 (ru) * | 1999-05-25 | 2000-01-20 | Институт ревматологии РАМН | Способ лечения ревматоидного артрита |
| CA2379747C (en) * | 1999-07-30 | 2008-09-23 | Boehringer Ingelheim Pharmaceuticals, Inc. | Novel succinate derivative compounds useful as cysteine protease inhibitors |
| CA2378499A1 (en) | 1999-08-04 | 2001-02-15 | Teijin Limited | Cyclic amine ccr3 antagonists |
| JP2001131145A (ja) | 1999-08-20 | 2001-05-15 | Toray Ind Inc | 光学活性３−アミノピロリジン誘導体の製造法 |
| ES2199856T3 (es) | 1999-09-13 | 2004-03-01 | Boehringer Ingelheim Pharmaceuticals, Inc. | Nuevos compuestos heterociclicos, utiles como inhibidores reversibles de cisteina proteasas. |
| GB2355263A (en) * | 1999-09-30 | 2001-04-18 | Merck & Co Inc | Lactam and cyclic urea derivatives useful as alpha 1a adrenoceptor antagonists |
| CA2384240A1 (en) | 1999-10-15 | 2001-04-26 | Dean A. Wacker | Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| WO2001045711A1 (en) | 1999-12-21 | 2001-06-28 | Smithkline Beecham Corporation | Urotensin-ii receptor antagonists |
| US6410566B1 (en) * | 2000-05-16 | 2002-06-25 | Teijin Limited | Cyclic amine derivatives and their use as drugs |
| GB0011838D0 (en) | 2000-05-17 | 2000-07-05 | Astrazeneca Ab | Chemical compounds |
| CA2425288A1 (en) | 2000-10-11 | 2002-05-02 | Sander G. Mills | Pyrrolidine modulators of ccr5 chemokine receptor activity |
| US20020094989A1 (en) * | 2000-10-11 | 2002-07-18 | Hale Jeffrey J. | Pyrrolidine modulators of CCR5 chemokine receptor activity |
| US6670364B2 (en) * | 2001-01-31 | 2003-12-30 | Telik, Inc. | Antagonists of MCP-1 function and methods of use thereof |
| EP1368354A1 (en) * | 2001-03-07 | 2003-12-10 | Pfizer Products Inc. | Modulators of chemokine receptor activity |
| US6538017B2 (en) | 2001-03-09 | 2003-03-25 | Ortho-Mcneil Pharmaceutical, Inc. | Aminopyrrolidine sulfonamides as serine protease inhibitors |
| DE60322877D1 (de) | 2002-04-29 | 2008-09-25 | Merck Sharp & Dohme | Tetrahydropyranylcyclopentyltetrahydroisochino-linmodulatoren der chemokinrezeptoraktivität |
| JO2479B1 (en) | 2002-04-29 | 2009-01-20 | ميرك شارب اند دوم ليمتد | Rates for the activity of the chemokine receptor of tetrahydrobranyl cycloneptil tetrahydrobredo predine |
| EP1501507B1 (en) | 2002-04-29 | 2008-05-28 | Merck & Co., Inc. | Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
| US7202249B2 (en) | 2002-08-27 | 2007-04-10 | Bristol-Myers Squibb Company | Antagonists of chemokine receptors |
| JP2004083511A (ja) | 2002-08-28 | 2004-03-18 | Yamanouchi Pharmaceut Co Ltd | アクリルアミド誘導体 |
| KR20050043967A (ko) | 2002-09-17 | 2005-05-11 | 액테리온 파마슈티칼 리미티드 | 1-피리딘-4-일-요소 유도체 |
| EP1558576A4 (en) | 2002-10-30 | 2008-04-16 | Merck & Co Inc | PIPERIDINYLCYCLOPENTYLARYLBENZYLAMIDE MODULATORS OF CHEMOKIN RECEPTORACTIVITY |
| WO2004041279A1 (en) | 2002-10-30 | 2004-05-21 | Merck & Co., Inc. | Gamma-aminoamide modulators of chemokine receptor activity |
| EP1558599A4 (en) | 2002-10-30 | 2007-06-27 | Merck & Co Inc | HETEROARYLPIPERIDINE MODULATORS DERCHEMOKIN RECEPTORACTIVITY |
| WO2004042351A2 (en) | 2002-10-30 | 2004-05-21 | Merck & Co., Inc. | Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity |
| CA2502174A1 (en) | 2002-10-30 | 2004-05-21 | Merck & Co., Inc. | Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| EP1565436B1 (en) | 2002-11-27 | 2012-04-25 | Incyte Corporation | 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| MXPA06004647A (es) | 2003-10-27 | 2006-06-27 | Merck & Co Inc | Sal antagonista de ccr-2. |
| AR045875A1 (es) | 2003-10-27 | 2005-11-16 | Merck & Co Inc | Procedimiento para la preparacion del antagonista ccr-2 |
| KR20080052683A (ko) * | 2003-12-18 | 2008-06-11 | 인사이트 코포레이션 | 케모킨 수용체의 조절제로서의3-사이클로알킬아미노피롤리딘 유도체 |
| US20070117797A1 (en) | 2004-01-02 | 2007-05-24 | Goble Stephen D | Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
| US7410961B2 (en) | 2004-01-20 | 2008-08-12 | Merck & Co., Inc. | 2,6-disubstituted piperiddines as modulators |
| CA2554387A1 (en) | 2004-01-28 | 2005-08-11 | Merck & Co., Inc. | Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity |
| EA015517B1 (ru) * | 2004-04-13 | 2011-08-30 | Инсайт Корпорейшн | Производные пиперазинилпиперидина в качестве антагонистов хемокинового рецептора |
| BRPI0510665A (pt) * | 2004-05-11 | 2007-12-04 | Incyte Corp | 3-(4-heteroarilcicloexilamino) ciclopentano-carboxiamidas como moduladores de receptores de quimiocinas |
| MXPA06014672A (es) * | 2004-06-28 | 2007-03-26 | Incyte Corp | 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas. |
| WO2006004741A2 (en) * | 2004-06-28 | 2006-01-12 | Incyte Corporation | 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| PA8653301A1 (es) | 2004-11-22 | 2006-11-09 | Incyte Corp Incyte Corp | Sales de la n-[2-({(3r)-1-[trans-4-hidroxi-4-(6-metoxipiridin-3-il) ciclohexil)pirrolidin |
| TWI449692B (zh) | 2005-05-13 | 2014-08-21 | Otsuka Pharma Co Ltd | 吡咯烷化合物（三） |
| MEP1008A (xx) * | 2005-12-21 | 2010-02-10 | Incyte Corp | 3-aminociklopentankarboksamidi kao modulatori receptora hemokina |
-
2003
- 2003-11-26 EP EP03790120A patent/EP1565436B1/en not_active Expired - Lifetime
- 2003-11-26 CA CA2507501A patent/CA2507501C/en not_active Expired - Lifetime
- 2003-11-26 RU RU2005120020/04A patent/RU2355679C2/ru active
- 2003-11-26 SG SG2007037260A patent/SG173922A1/en unknown
- 2003-11-26 AT AT03790120T patent/ATE555087T1/de active
- 2003-11-26 AU AU2003293129A patent/AU2003293129B2/en not_active Expired
- 2003-11-26 WO PCT/US2003/037946 patent/WO2004050024A2/en not_active Ceased
- 2003-11-26 PL PL376925A patent/PL376925A1/pl unknown
- 2003-11-26 MX MXPA05005660A patent/MXPA05005660A/es active IP Right Grant
- 2003-11-26 BR BRPI0316732A patent/BRPI0316732B8/pt not_active IP Right Cessation
- 2003-11-26 ES ES03790120T patent/ES2383296T3/es not_active Expired - Lifetime
- 2003-11-26 CN CN201110045106.XA patent/CN102153539B/zh not_active Expired - Lifetime
- 2003-11-26 GE GEAP20038862A patent/GEP20115290B/en unknown
- 2003-11-26 NZ NZ540290A patent/NZ540290A/en not_active IP Right Cessation
- 2003-11-26 US US10/535,795 patent/US7834021B2/en not_active Expired - Lifetime
- 2003-11-26 EP EP11175373A patent/EP2431357A3/en not_active Withdrawn
- 2003-11-26 HU HU0500848A patent/HU230612B1/hu unknown
- 2003-11-26 JP JP2004570963A patent/JP4828829B2/ja not_active Expired - Lifetime
- 2003-11-26 EA EA200500875A patent/EA010027B1/ru unknown
- 2003-11-26 KR KR1020057009692A patent/KR100895968B1/ko not_active Expired - Lifetime
-
2005
- 2005-05-23 IL IL168742A patent/IL168742A/en active IP Right Grant
- 2005-05-23 CR CR7846A patent/CR7846A/es unknown
- 2005-05-26 SE SE0501185A patent/SE529361C2/sv not_active IP Right Cessation
- 2005-05-26 NO NO20052543A patent/NO330860B1/no not_active IP Right Cessation
- 2005-06-01 CO CO05053243A patent/CO5690550A2/es active IP Right Grant
- 2005-06-15 EC EC2005005856A patent/ECSP055856A/es unknown
- 2005-06-22 IS IS7905A patent/IS2892B/is unknown
-
2009
- 2009-04-27 US US12/430,446 patent/US7985730B2/en not_active Expired - Lifetime
-
2011
- 2011-06-16 US US13/162,286 patent/US8362003B2/en not_active Expired - Fee Related
- 2011-07-21 JP JP2011160080A patent/JP2011251987A/ja active Pending
-
2012
- 2012-03-27 CR CR20120152A patent/CR20120152A/es unknown
- 2012-12-20 US US13/722,740 patent/US8729063B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006516145A5 (https=) | ||
| CA2507501A1 (en) | 3-aminopyrrolidine derivatives as modulators of chemokine receptors | |
| RU2454405C2 (ru) | Производные 3-пиридинкарбоксамида и 2-пиразинкарбоксамида в качестве агентов, повышающих уровень лвп-холестерина | |
| HRP20210431T1 (hr) | Pripravci tetrahidrokinolina kao inhibitori bet bromodomene | |
| KR20070008536A (ko) | 케모킨 수용체의 조절제로서의3-사이클로알킬아미노피롤리딘 유도체 | |
| JP2011503194A5 (https=) | ||
| US20060052374A1 (en) | Amino-tetrazole analogues and methods of use | |
| JP2010533158A5 (https=) | ||
| JP2021511363A5 (https=) | ||
| RU2019117556A (ru) | Индазольные производные, пригодные в качестве ингибиторов диацилглицерид o-ацилтрансферазы 2 | |
| RU2017124425A (ru) | Производные 2,4-диоксо-хиназолин-6-сульфонамида в качестве ингибиторов parg | |
| HRP20151064T1 (hr) | Amido spojevi i njihova upotreba kao farmaceutski proizvodi | |
| RU2009115830A (ru) | Пиридинкарбоксамиды в качестве ингибиторов 11-бета-hsd1 | |
| HRP20192323T1 (hr) | Novi derivati dihidrokinolin-2-ona | |
| RU2012146246A (ru) | Антибактериальные производные изохинолин-3-илмочевины | |
| JP2016514709A5 (https=) | ||
| RU2015144485A (ru) | Геминально-замещенные цианоэтилпиразолопиридоны в качестве ингибиторов janus киназ | |
| JP2016518344A5 (https=) | ||
| JP2008526840A5 (https=) | ||
| JP2014513122A5 (https=) | ||
| RU2019117958A (ru) | Производные индола, полезные в качестве ингибиторов диацилглицерид-о-ацилтрансферазы 2 | |
| RU2010136707A (ru) | Новые гетероциклы | |
| WO2015164520A4 (en) | Substituted 2,4,5,6-tetrahydropyrrolo[3,4-c] pyrazole and 4,5,6,7-tetrahydro-2h-pyrazolo [4,3-c] pyridine compounds as glyt1 inhibitors | |
| JPWO2020203609A5 (https=) | ||
| JP2009539998A5 (https=) |